CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | menadione |
|
Accession: | CHEBI:28869
|
browse the term
|
Definition: | A member of the class of 1,4-naphthoquinones that is 1,4-naphthoquinone which is substituted at position 2 by a methyl group. It is used as a nutritional supplement and for the treatment of hypoprothrombinemia. |
Synonyms: | exact_synonym: | 2-methylnaphthalene-1,4-dione |
| related_synonym: | 2-Methyl-1,4-naphthochinon; 2-Methyl-1,4-naphthoquinone; 2-methyl-1,4-naphthalenedione; 2-methylnaphthoquinone; 3-methyl-1,4-naphthoquinone; Aquakay; Aquinone; Formula=C11H8O2; Hemodal; InChI=1S/C11H8O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6H,1H3; InChIKey=MJVAVZPDRWSRRC-UHFFFAOYSA-N; Kappaxin; SMILES=CC1=CC(=O)C2=C(C=CC=C2)C1=O; Vitamin K3; menadion; menaphthon; menaphthone; menaquinone; menaquinone 0 |
| alt_id: | CHEBI:27304; CHEBI:46306; CHEBI:6747 |
| xref: | CAS:58-27-5; Chemspider:3915; DrugBank:DB00170; Drug_Central:1683; FooDB:FDB000953; HMDB:HMDB0001892; KEGG:C05377; KEGG:D02335; LINCS:LSM-3755 |
| xref_mesh: | MESH:D024483 |
| xref: | MetaCyc:CPD-3766; PDBeChem:VK3; PMID:10433694; PMID:11372776; PMID:12665684; PMID:12895502; PMID:13779073; PMID:15052609; PMID:15265851; PMID:15613473; PMID:15722567; PMID:16109308; PMID:16140270; PMID:16469140; PMID:1650428; PMID:1697141; PMID:1857739; PMID:18698499; PMID:19593550; PMID:19766112; PMID:2064595; PMID:2333843; PMID:28166217; PMID:30119016; PMID:30609653; PMID:3083821; PMID:31238027; PMID:31520616; PMID:31701430; PMID:32630491; PMID:32798378; PMID:33227312; PMID:33800926; PMID:33901557; PMID:33945810; PMID:34040527; PMID:8785182; PMID:9010592; PMID:9380028; Reaxys:1908453; Wikipedia:Menadione |
|
|
|
G |
A2m |
alpha-2-macroglobulin |
affects expression |
ISO |
Vitamin K 3 affects the expression of A2M mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of ABCB11 mRNA |
CTD |
PMID:34767876 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb7 |
ATP binding cassette subfamily B member 7 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ABCB7 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr X:69,295,598...69,436,775
Ensembl chr X:69,295,552...69,436,858
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ABCC3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcd4 |
ATP binding cassette subfamily D member 4 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of ABCD4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 6:104,246,459...104,260,965
Ensembl chr 6:104,246,468...104,280,276
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ABCG2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Abhd14b |
abhydrolase domain containing 14b |
affects expression |
ISO |
Vitamin K 3 affects the expression of ABHD14B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:107,087,157...107,092,122
Ensembl chr 8:107,088,069...107,092,119
|
|
G |
Abhd4 |
abhydrolase domain containing 4, N-acyl phospholipase B |
increases expression |
ISO |
Vitamin K 3 results in increased expression of ABHD4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr15:27,697,384...27,716,013
Ensembl chr15:27,704,113...27,716,966
|
|
G |
Abhd5 |
abhydrolase domain containing 5, lysophosphatidic acid acyltransferase |
affects expression |
ISO |
Vitamin K 3 affects the expression of ABHD5 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:122,000,241...122,026,447
Ensembl chr 8:122,000,389...122,026,447
|
|
G |
Abr |
ABR activator of RhoGEF and GTPase |
affects expression |
ISO |
Vitamin K 3 affects the expression of ABR mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:61,262,516...61,461,331
Ensembl chr10:61,262,516...61,461,505
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ACAT2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
|
|
G |
Aco1 |
aconitase 1 |
affects activity |
ISO |
Vitamin K 3 affects the activity of ACO1 protein |
CTD |
PMID:10037708 |
|
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
|
|
G |
Aco2 |
aconitase 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ACO2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 7:113,385,677...113,428,794
Ensembl chr 7:113,385,646...113,428,261
|
|
G |
Acot13 |
acyl-CoA thioesterase 13 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ACOT13 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:40,240,378...40,252,851
Ensembl chr17:40,240,378...40,252,851
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ACSL1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
|
|
G |
Acss1 |
acyl-CoA synthetase short-chain family member 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ACSS1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325
|
|
G |
Actr3b |
actin related protein 3B |
affects expression |
ISO |
Vitamin K 3 affects the expression of ACTR3B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:9,261,631...9,355,496
Ensembl chr 4:9,262,233...9,355,441
|
|
G |
Adam19 |
ADAM metallopeptidase domain 19 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of ADAM19 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr10:30,491,362...30,583,115
Ensembl chr10:30,491,405...30,583,105
|
|
G |
Adam9 |
ADAM metallopeptidase domain 9 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ADAM9 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr16:67,022,538...67,101,647
Ensembl chr16:67,022,655...67,100,917
|
|
G |
Adcy3 |
adenylate cyclase 3 |
affects expression decreases expression |
ISO |
Vitamin K 3 affects the expression of ADCY3 mRNA Vitamin K 3 results in decreased expression of ADCY3 mRNA |
CTD |
PMID:12414654 PMID:20044591 |
|
NCBI chr 6:27,100,089...27,203,686
Ensembl chr 6:27,124,828...27,203,686
|
|
G |
Add3 |
adducin 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ADD3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
|
|
G |
Adgra3 |
adhesion G protein-coupled receptor A3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ADGRA3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr14:60,874,719...60,976,341
Ensembl chr14:60,874,715...60,976,332
|
|
G |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ADGRV1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:11,331,434...11,911,713
Ensembl chr 2:11,331,442...11,911,688
|
|
G |
Adk |
adenosine kinase |
affects expression |
ISO |
Vitamin K 3 affects the expression of ADK mRNA |
CTD |
PMID:20044591 |
|
NCBI chr15:2,863,241...3,246,453
Ensembl chr15:2,863,244...3,246,510
|
|
G |
Ago1 |
argonaute RISC component 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of AGO1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:138,722,111...138,757,118
Ensembl chr 5:138,722,111...138,773,546
|
|
G |
Agpat3 |
1-acylglycerol-3-phosphate O-acyltransferase 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of AGPAT3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr20:10,330,960...10,415,358
Ensembl chr20:10,384,507...10,415,358
|
|
G |
Agr2 |
anterior gradient 2, protein disulphide isomerase family member |
affects expression |
ISO |
Vitamin K 3 affects the expression of AGR2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:52,708,602...52,729,378
Ensembl chr 6:52,708,602...52,729,371
|
|
G |
Ahr |
aryl hydrocarbon receptor |
affects expression |
ISO |
Vitamin K 3 affects the expression of AHR mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aire |
autoimmune regulator |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of AIRE mRNA |
CTD |
PMID:25270620 |
|
NCBI chr20:10,636,058...10,651,060
Ensembl chr20:10,636,123...10,651,060
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
affects expression |
ISO |
Vitamin K 3 affects the expression of AKAP12 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
|
|
G |
Akap9 |
A-kinase anchoring protein 9 |
affects expression |
ISO |
Vitamin K 3 affects the expression of AKAP9 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606
|
|
G |
Akip1 |
A-kinase interacting protein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of AKIP1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:163,734,730...163,743,648
Ensembl chr 1:163,734,798...163,743,648
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of AKR1B10 mRNA |
CTD |
PMID:23410634 PMID:34767876 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of AKR1C1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of AKR1C2 mRNA |
CTD |
PMID:12414654 PMID:23410634 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr7a2 |
aldo-keto reductase family 7, member A2 |
multiple interactions decreases response to substance increases metabolic processing |
ISO |
AKR7A2 protein inhibits the reaction [Vitamin K 3 results in decreased abundance of Glutathione]; AKR7A2 protein inhibits the reaction [Vitamin K 3 results in increased abundance of Reactive Oxygen Species] AKR7A2 protein results in decreased susceptibility to Vitamin K 3 AKR7A5 protein results in increased metabolism of Vitamin K 3 |
CTD |
PMID:22001351 PMID:24590062 |
|
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
|
|
G |
Alb |
albumin |
affects expression |
ISO |
Vitamin K 3 affects the expression of ALB mRNA |
CTD |
PMID:20044591 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh18a1 |
aldehyde dehydrogenase 18 family, member A1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ALDH18A1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:239,375,657...239,407,956
Ensembl chr 1:239,375,669...239,407,890
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ALDH1A1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ALDH1A3 mRNA |
CTD |
PMID:20829426 |
|
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
affects expression |
ISO |
Vitamin K 3 affects the expression of ALDH2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Aldh3b1 |
aldehyde dehydrogenase 3 family, member B1 |
decreases response to substance |
ISO |
ALDH3B1 protein results in decreased susceptibility to Vitamin K 3 |
CTD |
PMID:20699116 |
|
NCBI chr 1:201,145,309...201,162,675
Ensembl chr 1:201,145,309...201,163,921
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ALDH6A1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
decreases secretion |
ISO |
Vitamin K 3 results in decreased secretion of ALPL protein |
CTD |
PMID:30453296 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Alyref |
Aly/REF export factor |
affects expression |
ISO |
Vitamin K 3 affects the expression of ALYREF mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:105,871,424...105,875,076
Ensembl chr10:105,871,306...105,875,069
|
|
G |
Amotl2 |
angiomotin like 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of AMOTL2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:103,303,368...103,319,161
Ensembl chr 8:103,302,992...103,318,910
|
|
G |
Anapc1 |
anaphase promoting complex subunit 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ANAPC1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:115,850,117...115,930,259
Ensembl chr 3:115,850,185...115,930,273
|
|
G |
Ang |
angiogenin |
affects expression |
ISO |
Vitamin K 3 affects the expression of ANG mRNA |
CTD |
PMID:20044591 |
|
NCBI chr15:24,312,711...24,323,361
|
|
G |
Ank3 |
ankyrin 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ANK3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
|
|
G |
Ankra2 |
ankyrin repeat family A member 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ANKRA2 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 2:29,612,867...29,623,748
Ensembl chr 2:29,612,925...29,623,730
|
|
G |
Ankrd11 |
ankyrin repeat domain containing 11 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ANKRD11 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:50,940,284...51,098,962
Ensembl chr19:50,940,299...51,098,962
|
|
G |
Ankrd37 |
ankyrin repeat domain 37 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of ANKRD37 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr16:46,268,933...46,271,971
Ensembl chr16:46,268,443...46,271,963
|
|
G |
Anks1a |
ankyrin repeat and sterile alpha motif domain containing 1A |
affects expression |
ISO |
Vitamin K 3 affects the expression of ANKS1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr20:5,963,658...6,117,139
Ensembl chr20:5,963,678...6,117,148
|
|
G |
Anks6 |
ankyrin repeat and sterile alpha motif domain containing 6 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ANKS6 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:61,309,183...61,350,596
Ensembl chr 5:61,309,183...61,350,596
|
|
G |
Anp32b |
acidic nuclear phosphoprotein 32 family member B |
affects expression |
ISO |
Vitamin K 3 affects the expression of ANP32B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:60,743,077...60,765,726
Ensembl chr 5:60,743,443...60,765,717
|
|
G |
Antkmt |
adenine nucleotide translocase lysine methyltransferase |
affects expression |
ISO |
Vitamin K 3 affects the expression of ANTKMT mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:14,812,274...14,814,798
Ensembl chr10:14,812,269...14,814,193
|
|
G |
Anxa13 |
annexin A13 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ANXA13 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 7:89,884,356...89,936,907
Ensembl chr 7:89,884,356...89,936,907
|
|
G |
Aox1 |
aldehyde oxidase 1 |
multiple interactions decreases activity |
ISO |
Vitamin K 3 inhibits the reaction [AOX1 protein results in increased metabolism of zoniporide] Vitamin K 3 results in decreased activity of AOX1 protein |
CTD |
PMID:20040581 |
|
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
|
|
G |
Apbb2 |
amyloid beta precursor protein binding family B member 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of APBB2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr14:41,557,918...41,878,622
Ensembl chr14:41,557,972...41,877,495
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
increases response to substance |
ISO |
APEX1 gene mutant form results in increased susceptibility to Vitamin K 3 |
CTD |
PMID:11454706 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Aplp2 |
amyloid beta precursor like protein 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of APLP2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:29,599,230...29,662,311
Ensembl chr 8:29,599,230...29,661,855
|
|
G |
Apoa1 |
apolipoprotein A1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of APOA1 mRNA |
CTD |
PMID:20829426 |
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Apoa5 |
apolipoprotein A5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of APOA5 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 8:46,561,180...46,563,818
Ensembl chr 8:46,561,229...46,563,816
|
|
G |
Apoc3 |
apolipoprotein C3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of APOC3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
|
|
G |
Apoe |
apolipoprotein E |
affects response to substance |
ISO |
APOE protein affects the susceptibility to Vitamin K 3 |
CTD |
PMID:28728140 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Apoh |
apolipoprotein H |
affects expression |
ISO |
Vitamin K 3 affects the expression of APOH mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:93,342,435...93,356,334
Ensembl chr10:93,310,977...93,356,329
|
|
G |
Aqp11 |
aquaporin 11 |
affects expression |
ISO |
Vitamin K 3 affects the expression of AQP11 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:152,046,515...152,056,675
Ensembl chr 1:152,046,517...152,056,725
|
|
G |
Areg |
amphiregulin |
increases expression |
ISO |
Vitamin K 3 results in increased expression of AREG mRNA |
CTD |
PMID:12414654 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Arg2 |
arginase 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ARG2 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arhgef7 |
Rho guanine nucleotide exchange factor 7 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ARHGEF7 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr16:77,671,021...77,782,593
Ensembl chr16:77,671,023...77,782,697
|
|
G |
Arid3a |
AT-rich interaction domain 3A |
affects expression |
ISO |
Vitamin K 3 affects the expression of ARID3A mRNA |
CTD |
PMID:20044591 PMID:23410634 |
|
NCBI chr 7:9,755,291...9,781,260
Ensembl chr 7:9,755,294...9,780,599
|
|
G |
Arid5a |
AT-rich interaction domain 5A |
affects expression |
ISO |
Vitamin K 3 affects the expression of ARID5A mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:38,534,612...38,549,467
Ensembl chr 9:38,534,590...38,547,597
|
|
G |
Armcx1 |
armadillo repeat containing, X-linked 1 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of ARMCX1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr X:97,898,969...97,902,874
Ensembl chr X:97,898,883...97,903,299
|
|
G |
Arrdc2 |
arrestin domain containing 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ARRDC2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr16:18,601,897...18,606,029
Ensembl chr16:18,601,897...18,606,029
|
|
G |
Asf1a |
anti-silencing function 1A histone chaperone |
increases expression |
ISO |
Vitamin K 3 results in increased expression of ASF1A mRNA |
CTD |
PMID:23410634 |
|
NCBI chr20:32,893,962...32,908,808
Ensembl chr20:32,893,573...32,908,808
|
|
G |
Asic1 |
acid sensing ion channel subunit 1 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of ASIC1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 7:130,798,317...130,828,535
Ensembl chr 7:130,799,917...130,828,541
|
|
G |
Atf3 |
activating transcription factor 3 |
affects expression increases expression |
ISO |
Vitamin K 3 affects the expression of ATF3 mRNA Vitamin K 3 results in increased expression of ATF3 mRNA |
CTD |
PMID:12414654 PMID:20044591 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf6 |
activating transcription factor 6 |
multiple interactions increases expression |
ISO |
Metyrapone promotes the reaction [Vitamin K 3 results in increased expression of ATF6 protein]; S 3483 promotes the reaction [Vitamin K 3 results in increased expression of ATF6 protein] |
CTD |
PMID:19819344 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atg5 |
autophagy related 5 |
affects response to substance |
EXP ISO |
ATG5 mRNA affects the susceptibility to Vitamin K 3 ATG5 protein affects the susceptibility to Vitamin K 3 |
CTD |
PMID:18073215 PMID:18319638 PMID:20578144 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atic |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
affects expression |
ISO |
Vitamin K 3 affects the expression of ATIC mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:73,164,846...73,184,897
Ensembl chr 9:73,164,846...73,184,889
|
|
G |
Atox1 |
antioxidant 1 copper chaperone |
affects expression |
ISO |
Vitamin K 3 affects the expression of ATOX1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:39,564,855...39,579,892
Ensembl chr10:39,564,857...39,579,950
|
|
G |
Atp5if1 |
ATP synthase inhibitory factor subunit 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ATP5IF1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:144,738,950...144,742,668
Ensembl chr 5:144,738,950...144,742,668
|
|
G |
Atp5po |
ATP synthase peripheral stalk subunit OSCP |
affects expression |
ISO |
Vitamin K 3 affects the expression of ATP5PO mRNA |
CTD |
PMID:20044591 |
|
NCBI chr11:31,165,218...31,171,530
Ensembl chr11:31,165,217...31,171,592
|
|
G |
Atp7b |
ATPase copper transporting beta |
affects expression |
ISO |
Vitamin K 3 affects the expression of ATP7B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
|
|
G |
Atrn |
attractin |
affects expression |
ISO |
Vitamin K 3 affects the expression of ATRN mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:118,110,320...118,244,326
Ensembl chr 3:118,110,229...118,244,322
|
|
G |
Atrx |
ATRX, chromatin remodeler |
affects expression |
ISO |
Vitamin K 3 affects the expression of ATRX mRNA |
CTD |
PMID:20829426 |
|
NCBI chr X:70,850,981...70,997,330
Ensembl chr X:70,850,981...70,997,330
|
|
G |
Atxn2l |
ataxin 2-like |
affects expression |
ISO |
Vitamin K 3 affects the expression of ATXN2L mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:181,078,293...181,090,079
Ensembl chr 1:181,078,288...181,089,686
|
|
G |
Auh |
AU RNA binding methylglutaconyl-CoA hydratase |
affects expression |
ISO |
Vitamin K 3 affects the expression of AUH mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:12,329,522...12,424,882
Ensembl chr17:12,329,524...12,424,896
|
|
G |
Aurkb |
aurora kinase B |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of AURKB mRNA |
CTD |
PMID:12414654 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
Auts2 |
activator of transcription and developmental regulator AUTS2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of AUTS2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr12:24,104,187...25,194,123
Ensembl chr12:24,104,192...25,194,416
|
|
G |
B3galt6 |
Beta-1,3-galactosyltransferase 6 |
affects expression |
ISO |
Vitamin K 3 affects the expression of B3GALT6 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:166,584,202...166,586,338
Ensembl chr 5:166,584,202...166,586,338
|
|
G |
Bahd1 |
bromo adjacent homology domain containing 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of BAHD1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:105,891,207...105,914,414
Ensembl chr 3:105,892,478...105,914,410
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of BAK1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bambi |
BMP and activin membrane-bound inhibitor |
affects expression |
ISO |
Vitamin K 3 affects the expression of BAMBI mRNA |
CTD |
PMID:23410634 |
|
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
|
|
G |
Batf |
basic leucine zipper ATF-like transcription factor |
increases expression |
ISO |
Vitamin K 3 results in increased expression of BATF mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 6:105,353,715...105,376,051
Ensembl chr 6:105,353,715...105,376,051
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
affects localization multiple interactions increases expression |
EXP ISO |
Vitamin K 3 affects the localization of BAX protein EUK-134 inhibits the reaction [Vitamin K 3 results in increased expression of BAX protein] |
CTD |
PMID:15961378 PMID:25005833 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of BBC3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bbs2 |
Bardet-Biedl syndrome 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of BBS2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:10,909,653...10,944,998
Ensembl chr19:10,909,619...10,944,993
|
|
G |
Bcar3 |
BCAR3 adaptor protein, NSP family member |
affects expression |
ISO |
Vitamin K 3 affects the expression of BCAR3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:210,525,260...210,638,674
Ensembl chr 2:210,525,260...210,638,798
|
|
G |
Bcas1 |
brain enriched myelin associated protein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of BCAS1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:159,136,077...159,219,072
Ensembl chr 3:159,136,083...159,219,106
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO EXP |
[sodium arsenite co-treated with Vitamin K 3] results in decreased expression of BCL2 protein; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in decreased expression of BCL2 protein]; EUK-134 inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 protein] Acetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 mRNA]; Acetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 protein] Vitamin K 3 results in decreased expression of BCL2 mRNA; Vitamin K 3 results in decreased expression of BCL2 protein |
CTD |
PMID:19082730 PMID:19265712 PMID:25005833 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl6 |
BCL6, transcription repressor |
affects expression |
ISO |
Vitamin K 3 affects the expression of BCL6 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
|
|
G |
Bcl9l |
BCL9 like |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of BCL9L protein |
CTD |
PMID:31238027 |
|
NCBI chr 8:44,811,977...44,840,611
Ensembl chr 8:44,811,977...44,840,611
|
|
G |
Bdh2 |
3-hydroxybutyrate dehydrogenase 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of BDH2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:223,702,410...223,723,076
Ensembl chr 2:223,702,412...223,723,072
|
|
G |
Becn1 |
beclin 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of BECN1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bet1l |
Bet1 golgi vesicular membrane trafficking protein-like |
affects expression |
ISO |
Vitamin K 3 affects the expression of BET1L mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:195,931,407...195,935,072
Ensembl chr 1:195,931,411...195,935,040
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
decreases expression multiple interactions increases expression increases secretion |
ISO |
Vitamin K 3 results in decreased expression of BGLAP mRNA Vitamin K 3 inhibits the reaction [Estrogens deficiency results in decreased secretion of BGLAP protein] Vitamin K 3 results in increased expression of BGLAP protein modified form Vitamin K 3 results in increased secretion of BGLAP protein |
CTD |
PMID:19675304 PMID:30453296 |
|
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
|
|
G |
Bik |
BCL2-interacting killer |
increases expression |
ISO |
Vitamin K 3 results in increased expression of BIK mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of BIRC5 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Blvrb |
biliverdin reductase B |
increases expression |
ISO |
Vitamin K 3 results in increased expression of BLVRB mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Bms1 |
BMS1 ribosome biogenesis factor |
affects expression |
ISO |
Vitamin K 3 affects the expression of BMS1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:151,558,163...151,595,187
Ensembl chr 4:151,558,163...151,595,127
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of BNIP3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Brd8 |
bromodomain containing 8 |
affects expression |
ISO |
Vitamin K 3 affects the expression of BRD8 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr18:26,204,892...26,229,999
Ensembl chr18:26,181,732...26,229,884
|
|
G |
Brms1 |
BRMS1, transcriptional repressor and anoikis regulator |
affects expression |
ISO |
Vitamin K 3 affects the expression of BRMS1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:202,345,766...202,355,028
Ensembl chr 1:202,345,704...202,355,028
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of BTG2 mRNA |
CTD |
PMID:12414654 PMID:21382384 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
affects expression |
ISO |
Vitamin K 3 affects the expression of BUB1 mRNA |
CTD |
PMID:20044591 PMID:23410634 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
Bud13 |
BUD13 homolog |
affects expression |
ISO |
Vitamin K 3 affects the expression of BUD13 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:46,575,124...46,590,964
Ensembl chr 8:46,575,115...46,590,958
|
|
G |
C10h17orf100 |
similar to human chromosome 17 open reading frame 100 |
affects expression |
ISO |
Vitamin K 3 affects the expression of C17ORF100 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr10:56,840,451...56,843,674
Ensembl chr10:56,832,412...56,843,871
|
|
G |
C11h3orf52 |
similar to human chromosome 3 open reading frame 52 |
affects expression |
ISO |
Vitamin K 3 affects the expression of C3ORF52 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr11:55,166,986...55,192,273
Ensembl chr11:55,166,678...55,192,292
|
|
G |
C17h6orf62 |
similar to human chromosome 6 open reading frame 62 |
affects expression |
ISO |
Vitamin K 3 affects the expression of C6ORF62 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr17:40,256,211...40,267,851
Ensembl chr17:40,256,211...40,276,020
|
|
G |
C1galt1c1 |
C1GALT1-specific chaperone 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of C1GALT1C1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr X:117,378,123...117,382,620
Ensembl chr X:117,375,525...117,382,787
|
|
G |
C1qbp |
complement C1q binding protein |
affects expression |
ISO |
Vitamin K 3 affects the expression of C1QBP mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:55,699,954...55,704,605
Ensembl chr10:55,699,954...55,704,649
|
|
G |
C2cd5 |
C2 calcium-dependent domain containing 5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of C2CD5 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:175,969,544...176,055,597
Ensembl chr 4:175,969,545...176,055,558
|
|
G |
C7h8orf76 |
similar to human chromosome 8 open reading frame 76 |
affects expression |
ISO |
Vitamin K 3 affects the expression of C8ORF76 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 7:89,558,890...89,569,810
Ensembl chr 7:89,558,909...89,569,810
|
|
G |
C8h15orf39 |
similar to human chromosome 15 open reading frame 39 |
affects expression |
ISO |
Vitamin K 3 affects the expression of C15ORF39 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:57,646,324...57,655,896
Ensembl chr 8:57,645,756...57,655,941
|
|
G |
Cables1 |
Cdk5 and Abl enzyme substrate 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CABLES1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr18:3,076,556...3,181,181
Ensembl chr18:3,075,524...3,181,181
|
|
G |
Cacna1g |
calcium voltage-gated channel subunit alpha1 G |
affects expression |
ISO |
Vitamin K 3 affects the expression of CACNA1G mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752
|
|
G |
Calb1 |
calbindin 1 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of CALB1 mRNA |
CTD |
PMID:30453296 |
|
NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:29,375,642...29,402,431
|
|
G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CAMK2N1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
|
|
G |
Canx |
calnexin |
affects expression |
ISO |
Vitamin K 3 affects the expression of CANX mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
|
|
G |
Capn2 |
calpain 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CAPN2 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
|
|
G |
Car12 |
carbonic anhydrase 12 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CA12 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
|
|
G |
Casp2 |
caspase 2 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of CASP2 protein modified form |
CTD |
PMID:20829426 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity increases expression increases cleavage |
ISO EXP |
[sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP3 protein; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP3 protein]; Vitamin K 3 analog inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; Vitamin K 3 analog promotes the reaction [Doxorubicin results in increased activity of CASP3 protein] Vitamin K 3 results in increased activity of CASP3 protein Vitamin K 3 results in increased expression of CASP3 protein modified form Buthionine Sulfoximine promotes the reaction [Vitamin K 3 results in increased activity of CASP3 protein]; pyrazolanthrone inhibits the reaction [Vitamin K 3 results in increased cleavage of CASP3 protein]; U 0126 promotes the reaction [Vitamin K 3 results in increased activity of CASP3 protein] |
CTD |
PMID:12965111 PMID:16310883 PMID:19082730 PMID:20829426 PMID:23300732 PMID:29141199 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
multiple interactions |
ISO |
[Metyrapone co-treated with Vitamin K 3] affects the localization of CASP4 protein; [S 3483 co-treated with Vitamin K 3] affects the localization of CASP4 protein |
CTD |
PMID:19819344 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp6 |
caspase 6 |
multiple interactions increases cleavage |
EXP |
pyrazolanthrone inhibits the reaction [Vitamin K 3 results in increased activity of CASP6 protein]; pyrazolanthrone inhibits the reaction [Vitamin K 3 results in increased cleavage of CASP6 protein] |
CTD |
PMID:16310883 |
|
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases cleavage |
ISO EXP |
[sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP9 protein; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP9 protein]; EUK-134 inhibits the reaction [Vitamin K 3 results in increased cleavage of CASP9 protein]; Vitamin K 3 analog promotes the reaction [Doxorubicin results in increased activity of CASP9 protein] pyrazolanthrone inhibits the reaction [Vitamin K 3 results in increased cleavage of CASP9 protein] |
CTD |
PMID:16310883 PMID:19082730 PMID:25005833 PMID:29141199 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
affects expression multiple interactions decreases response to substance decreases activity |
ISO EXP |
Vitamin K 3 affects the expression of CAT mRNA [CAT protein co-treated with SOD1 protein] results in decreased susceptibility to Vitamin K 3; [CAT protein co-treated with SOD2 protein] results in decreased susceptibility to Vitamin K 3; CAT protein inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; CAT protein inhibits the reaction [[DCXR protein results in increased metabolism of Vitamin K 3] which results in increased chemical synthesis of Hydrogen Peroxide]; CAT results in decreased susceptibility to [Vitamin K 3 co-treated with Ascorbic Acid] CAT protein results in decreased susceptibility to Vitamin K 3 Vitamin K 3 results in decreased activity of CAT protein |
CTD |
PMID:12633745 PMID:14698046 PMID:15331536 PMID:20044591 PMID:21689642 PMID:22486562 PMID:28595002 PMID:30536483 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cavin2 |
caveolae associated protein 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CAVIN2 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 9:50,302,079...50,314,096
Ensembl chr 9:50,301,206...50,314,147
|
|
G |
Cbfb |
core-binding factor subunit beta |
affects expression |
ISO |
Vitamin K 3 affects the expression of CBFB mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:33,049,162...33,092,752
Ensembl chr19:33,049,172...33,092,751
|
|
G |
Cbr1 |
carbonyl reductase 1 |
multiple interactions increases metabolic processing |
ISO |
[S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of Vitamin K 3]; Vitamin K 3 inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] |
CTD |
PMID:11306090 PMID:19061875 PMID:23295225 |
|
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Cbr3 |
carbonyl reductase 3 |
affects metabolic processing increases expression |
ISO |
CBR3 protein affects the metabolism of Vitamin K 3 Vitamin K 3 results in increased expression of CBR3 mRNA |
CTD |
PMID:20007405 PMID:21382384 PMID:25270620 |
|
NCBI chr11:33,008,615...33,016,877
Ensembl chr11:33,008,615...33,016,875
|
|
G |
Ccar2 |
cell cycle and apoptosis regulator 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CCAR2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr15:45,212,797...45,228,001
Ensembl chr15:45,212,803...45,227,636
|
|
G |
Ccdc12 |
coiled-coil domain containing 12 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CCDC12 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:110,635,276...110,686,417
Ensembl chr 8:110,635,710...110,686,417
|
|
G |
Ccdc125 |
coiled-coil domain containing 125 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CCDC125 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:31,809,120...31,835,538
Ensembl chr 2:31,809,228...31,850,152
|
|
G |
Ccdc136 |
coiled-coil domain containing 136 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of CCDC136 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 4:57,997,825...58,027,598
Ensembl chr 4:57,997,853...58,027,646
|
|
G |
Ccdc88b |
coiled-coil domain containing 88B |
affects expression |
ISO |
Vitamin K 3 affects the expression of CCDC88B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:204,036,913...204,052,878
Ensembl chr 1:204,036,918...204,052,970
|
|
G |
Ccdc90b |
coiled-coil domain containing 90B |
affects expression |
ISO |
Vitamin K 3 affects the expression of CCDC90B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:146,632,756...146,646,314
Ensembl chr 1:146,633,036...146,647,338
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
multiple interactions increases expression increases secretion |
EXP |
Acetaminophen inhibits the reaction [Vitamin K 3 results in increased expression of CCL3 mRNA]; Acetaminophen inhibits the reaction [Vitamin K 3 results in increased secretion of CCL3 protein] |
CTD |
PMID:19265712 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions increases expression increases secretion |
EXP |
Acetaminophen inhibits the reaction [Vitamin K 3 results in increased expression of CCL5 mRNA]; Acetaminophen inhibits the reaction [Vitamin K 3 results in increased secretion of CCL5 protein] |
CTD |
PMID:19265712 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccn1 |
cellular communication network factor 1 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of CCN1 mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccn2 |
cellular communication network factor 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CCN2 mRNA |
CTD |
PMID:20044591 PMID:23410634 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression affects expression |
ISO |
Vitamin K 3 results in decreased expression of CCNA2 mRNA Vitamin K 3 affects the expression of CCNA2 mRNA |
CTD |
PMID:12414654 PMID:23410634 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb2 |
cyclin B2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CCNB2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccnd1 |
cyclin D1 |
affects expression decreases expression |
ISO |
Vitamin K 3 affects the expression of CCND1 mRNA Vitamin K 3 results in decreased expression of CCND1 protein |
CTD |
PMID:20044591 PMID:31238027 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CCNE1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccng1 |
cyclin G1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CCNG1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Ccni |
cyclin I |
affects expression |
ISO |
Vitamin K 3 affects the expression of CCNI mRNA |
CTD |
PMID:20044591 |
|
NCBI chr14:14,879,698...14,902,510
Ensembl chr14:14,879,717...14,902,510
|
|
G |
Ccnjl |
cyclin J-like |
affects expression |
ISO |
Vitamin K 3 affects the expression of CCNJL mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:27,995,682...28,053,428
Ensembl chr10:27,995,679...28,053,426
|
|
G |
Ccnq |
cyclin Q |
affects expression |
ISO |
Vitamin K 3 affects the expression of CCNQ mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:63,646,532...63,647,695
Ensembl chr10:63,646,527...63,647,961
|
|
G |
Cct2 |
chaperonin containing TCP1 subunit 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CCT2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 7:52,692,725...52,705,478
Ensembl chr 7:52,692,725...52,706,944
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CCT5 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:82,591,750...82,602,903
Ensembl chr 2:82,590,630...82,602,930
|
|
G |
Cd1d1 |
CD1d1 molecule |
affects expression |
ISO |
Vitamin K 3 affects the expression of CD1D mRNA |
CTD |
PMID:20829426 |
|
NCBI chr 2:172,423,582...172,427,089
Ensembl chr 2:172,423,582...172,427,089
|
|
G |
Cd36 |
CD36 molecule |
affects expression |
ISO |
Vitamin K 3 affects the expression of CD36 mRNA |
CTD |
PMID:20829426 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd44 |
CD44 molecule |
affects expression |
ISO |
Vitamin K 3 affects the expression of CD44 mRNA |
CTD |
PMID:20829426 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd48 |
Cd48 molecule |
affects expression |
ISO |
Vitamin K 3 affects the expression of CD48 mRNA |
CTD |
PMID:20829426 |
|
NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142
|
|
G |
Cd74 |
CD74 molecule |
affects expression |
ISO |
Vitamin K 3 affects the expression of CD74 mRNA |
CTD |
PMID:20829426 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
Cd9 |
CD9 molecule |
affects expression |
ISO |
Vitamin K 3 affects the expression of CD9 mRNA |
CTD |
PMID:20044591 PMID:23410634 |
|
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
|
|
G |
Cdc14b |
cell division cycle 14B |
affects expression |
ISO |
Vitamin K 3 affects the expression of CDC14B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:844,686...934,787
Ensembl chr17:844,685...933,235
|
|
G |
Cdc42ep4 |
CDC42 effector protein 4 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CDC42EP4 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr10:98,772,613...98,797,924
Ensembl chr10:98,772,495...98,797,695
|
|
G |
Cdc45 |
cell division cycle 45 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CDC45 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
|
|
G |
Cdca5 |
cell division cycle associated 5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CDCA5 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023
|
|
G |
Cdca7 |
cell division cycle associated 7 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CDCA7 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:57,322,718...57,333,353
Ensembl chr 3:57,322,708...57,333,353
|
|
G |
Cdh1 |
cadherin 1 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of CDH1 protein |
CTD |
PMID:31238027 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh16 |
cadherin 16 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CDH16 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:360,824...371,008
Ensembl chr19:360,824...371,007
|
|
G |
Cdh2 |
cadherin 2 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of CDH2 protein |
CTD |
PMID:31238027 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of CDK4 mRNA |
CTD |
PMID:16010434 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions increases expression |
ISO |
[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1A protein; EUK-134 affects the reaction [Vitamin K 3 results in increased expression of CDKN1A protein]; SB 203580 inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1A protein] Vitamin K 3 results in increased expression of CDKN1A mRNA; Vitamin K 3 results in increased expression of CDKN1A protein |
CTD |
PMID:12414654 PMID:19082730 PMID:23410634 PMID:25005833 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
ISO |
[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1B protein; SB 203580 inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1B protein] |
CTD |
PMID:19082730 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
affects expression |
ISO |
Vitamin K 3 affects the expression of CDKN1C mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
increases expression |
ISO |
Vitamin K 3 results in increased expression of CDKN2A mRNA |
CTD |
PMID:16010434 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CDT1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
|
|
G |
Cdx1 |
caudal type homeo box 1 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of CDX1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr18:54,472,587...54,490,913
Ensembl chr18:54,473,444...54,490,814
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
affects expression |
ISO |
Vitamin K 3 affects the expression of CEBPA mRNA |
CTD |
PMID:20044591 PMID:23410634 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cenpa |
centromere protein A |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of CENPA mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
|
|
G |
Cenpf |
centromere protein F |
affects expression |
ISO |
Vitamin K 3 affects the expression of CENPF mRNA |
CTD |
PMID:20044591 |
|
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
|
|
G |
Cep95 |
centrosomal protein 95 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CEP95 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:91,732,111...91,760,095
Ensembl chr10:91,732,111...91,760,092
|
|
G |
Cfap20 |
cilia and flagella associated protein 20 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CFAP20 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:9,608,867...9,622,558
Ensembl chr19:9,608,859...9,622,558
|
|
G |
Cgnl1 |
cingulin-like 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CGNL1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:72,273,401...72,424,842
Ensembl chr 8:72,275,645...72,422,917
|
|
G |
Chek1 |
checkpoint kinase 1 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of CHEK1 mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chka |
choline kinase alpha |
affects expression |
ISO |
Vitamin K 3 affects the expression of CHKA mRNA |
CTD |
PMID:20044591 PMID:23410634 |
|
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
|
|
G |
Chpf2 |
chondroitin polymerizing factor 2 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of CHPF2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 4:10,578,470...10,585,940
Ensembl chr 4:10,580,462...10,585,916
|
|
G |
Chst15 |
carbohydrate sulfotransferase 15 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CHST15 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 1:187,028,860...187,107,908
Ensembl chr 1:187,028,970...187,107,707
|
|
G |
Chst7 |
carbohydrate sulfotransferase 7 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CHST7 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr X:2,396,260...2,432,828
Ensembl chr X:2,393,874...2,432,840
|
|
G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CITED2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
|
|
G |
Ckap5 |
cytoskeleton associated protein 5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CKAP5 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:77,491,195...77,593,300
Ensembl chr 3:77,491,276...77,593,264
|
|
G |
Ckb |
creatine kinase B |
affects expression |
ISO |
Vitamin K 3 affects the expression of CKB mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Cks1b |
CDC28 protein kinase regulatory subunit 1B |
affects expression |
ISO |
Vitamin K 3 affects the expression of CKS1B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636
|
|
G |
Cldn23 |
claudin 23 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CLDN23 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr16:56,413,677...56,415,401
Ensembl chr16:56,413,381...56,415,523
|
|
G |
Cldn3 |
claudin 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CLDN3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
|
|
G |
Clip1 |
CAP-GLY domain containing linker protein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CLIP1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr12:32,910,932...33,017,891
Ensembl chr12:32,910,977...33,017,884
|
|
G |
Clpb |
ClpB family mitochondrial disaggregase |
affects expression |
ISO |
Vitamin K 3 affects the expression of CLPB mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:156,028,740...156,158,183
Ensembl chr 1:156,028,930...156,168,788
|
|
G |
Cmbl |
carboxymethylenebutenolidase homolog |
affects expression |
ISO |
Vitamin K 3 affects the expression of CMBL mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:82,571,888...82,591,009
|
|
G |
Cmip |
c-Maf-inducing protein |
affects expression |
ISO |
Vitamin K 3 affects the expression of CMIP mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:45,304,597...45,510,653
Ensembl chr19:45,304,031...45,508,709
|
|
G |
Cmtm3 |
CKLF-like MARVEL transmembrane domain containing 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CMTM3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:622,563...630,721
Ensembl chr19:604,458...629,790
|
|
G |
Cntnap2 |
contactin associated protein 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CNTNAP2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:74,109,455...76,366,434
Ensembl chr 4:74,109,472...76,362,027
|
|
G |
Coa4 |
cytochrome c oxidase assembly factor 4 homolog |
affects expression |
ISO |
Vitamin K 3 affects the expression of COA4 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:154,882,199...154,885,445
Ensembl chr 1:154,882,155...154,888,174
|
|
G |
Coa5 |
cytochrome C oxidase assembly factor 5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of COA5 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:39,651,459...39,664,870
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of COL1A1 mRNA |
CTD |
PMID:19675304 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
affects expression |
ISO |
Vitamin K 3 affects the expression of COL5A2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
|
|
G |
Coro2a |
coronin 2A |
affects expression |
ISO |
Vitamin K 3 affects the expression of CORO2A mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:60,825,630...60,881,917
Ensembl chr 5:60,828,247...60,859,035
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
ISO |
[sodium arsenite co-treated with Vitamin K 3] results in increased phosphorylation of CREB1 protein |
CTD |
PMID:19082730 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crip1 |
cysteine rich protein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CRIP1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:132,226,746...132,234,620
Ensembl chr 6:132,226,746...132,234,620
|
|
G |
Cryl1 |
crystallin, lambda 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CRYL1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr15:31,427,011...31,545,997
Ensembl chr15:31,427,054...31,545,997
|
|
G |
Ctbp2 |
C-terminal binding protein 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CTBP2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:187,782,064...187,918,115
Ensembl chr 1:187,782,682...187,920,222
|
|
G |
Ctf1 |
cardiotrophin 1 |
multiple interactions increases expression |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Vitamin K 3 results in increased expression of CTF1 protein]; 2-methoxyestradiol inhibits the reaction [Vitamin K 3 results in increased expression of CTF1 protein]; 6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole inhibits the reaction [Vitamin K 3 results in increased expression of CTF1 protein]; acetovanillone inhibits the reaction [Vitamin K 3 results in increased expression of CTF1 protein]; diphenyleneiodonium inhibits the reaction [Vitamin K 3 results in increased expression of CTF1 protein]; pyrazolanthrone inhibits the reaction [Vitamin K 3 results in increased expression of CTF1 protein]; U 0126 inhibits the reaction [Vitamin K 3 results in increased expression of CTF1 protein] Vitamin K 3 results in increased expression of CTF1 mRNA; Vitamin K 3 results in increased expression of CTF1 protein |
CTD |
PMID:16507596 |
|
NCBI chr 1:182,328,035...182,336,346
Ensembl chr 1:182,328,090...182,333,335
|
|
G |
Ctnnb1 |
catenin beta 1 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of CTNNB1 protein |
CTD |
PMID:31238027 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctnnd1 |
catenin delta 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CTNND1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:69,683,328...69,734,550
Ensembl chr 3:69,683,313...69,734,516
|
|
G |
Ctps1 |
CTP synthase 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CTPS1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180
|
|
G |
Ctr9 |
CTR9 homolog, Paf1/RNA polymerase II complex component |
affects expression |
ISO |
Vitamin K 3 affects the expression of CTR9 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:165,137,277...165,167,303
Ensembl chr 1:165,137,215...165,167,303
|
|
G |
Cul4a |
cullin 4A |
affects expression |
ISO |
Vitamin K 3 affects the expression of CUL4A mRNA |
CTD |
PMID:20044591 |
|
NCBI chr16:76,385,298...76,422,316
Ensembl chr16:76,384,546...76,422,330
|
|
G |
Cxxc5 |
CXXC finger protein 5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CXXC5 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr18:27,427,591...27,458,579
Ensembl chr18:27,427,230...27,458,673
|
|
G |
Cyb5d2 |
cytochrome b5 domain containing 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CYB5D2 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr10:57,394,268...57,413,336
Ensembl chr10:57,396,765...57,413,715
|
|
G |
Cyb5r1 |
cytochrome b5 reductase 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CYB5R1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr13:45,849,017...45,855,458
Ensembl chr13:45,849,091...45,855,458
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
increases expression |
ISO |
Vitamin K 3 results in increased expression of CYBA protein |
CTD |
PMID:16507596 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases activity increases expression |
ISO EXP |
Vitamin K 3 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] Vitamin K 3 results in increased activity of CYP1A1 protein Vitamin K 3 results in increased expression of CYP1A1 mRNA |
CTD |
PMID:15603920 PMID:18493746 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions increases activity increases expression |
ISO EXP |
Vitamin K 3 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] Vitamin K 3 results in increased activity of CYP1A2 protein Vitamin K 3 results in increased expression of CYP1A2 mRNA |
CTD |
PMID:15603920 PMID:18493746 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of CYP1B1 mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CYP24A1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases expression multiple interactions |
ISO |
Vitamin K 3 results in decreased expression of CYP2E1 mRNA [CYP2E1 protein co-treated with Vitamin K 3 co-treated with Arachidonic Acid] results in increased expression of KLF6 protein; [CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein; Buthionine Sulfoximine promotes the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; CAT protein inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Dicumarol inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; S-ethyl glutathione inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Vitamin E inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Vitamin K 3 promotes the reaction [CYP2E1 protein results in increased expression of KLF6 mRNA alternative form]; Vitamin K 3 promotes the reaction [CYP2E1 protein results in increased expression of KLF6 mRNA] |
CTD |
PMID:22486562 PMID:25270620 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CYP2J9 mRNA |
CTD |
PMID:20829426 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp2r1 |
cytochrome P450, family 2, subfamily r, polypeptide 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of CYP2R1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:168,749,302...168,798,079
Ensembl chr 1:168,751,038...168,797,759
|
|
G |
Dbi |
diazepam binding inhibitor |
affects expression |
ISO |
Vitamin K 3 affects the expression of DBI mRNA |
CTD |
PMID:20044591 |
|
NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
|
|
G |
Dcp1b |
decapping mRNA 1B |
affects expression |
ISO |
Vitamin K 3 affects the expression of DCP1B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:152,358,267...152,395,747
Ensembl chr 4:152,358,241...152,397,145
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
multiple interactions decreases activity increases metabolic processing |
ISO |
[DCXR protein results in increased metabolism of Vitamin K 3] which results in increased chemical synthesis of Hydrogen Peroxide; [DCXR protein results in increased metabolism of Vitamin K 3] which results in increased chemical synthesis of Superoxides; [Vitamin K 3 co-treated with NADP] binds to DCXR protein; CAT protein inhibits the reaction [[DCXR protein results in increased metabolism of Vitamin K 3] which results in increased chemical synthesis of Hydrogen Peroxide]; Diacetyl inhibits the reaction [[DCXR protein results in increased metabolism of Vitamin K 3] which results in increased chemical synthesis of Superoxides]; Vitamin K 3 inhibits the reaction [[[DCXR protein co-treated with NAD] results in increased reduction of Diacetyl] which results in increased chemical synthesis of Acetoin] Vitamin K 3 results in decreased activity of DCXR protein |
CTD |
PMID:25526675 PMID:28595002 |
|
NCBI chr10:106,006,404...106,008,293
|
|
G |
Ddc |
dopa decarboxylase |
affects expression |
ISO |
Vitamin K 3 affects the expression of DDC mRNA |
CTD |
PMID:20044591 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression multiple interactions |
ISO |
Vitamin K 3 results in increased expression of DDIT3 mRNA; Vitamin K 3 results in increased expression of DDIT3 protein Metyrapone promotes the reaction [Vitamin K 3 results in increased expression of DDIT3 protein]; S 3483 promotes the reaction [Vitamin K 3 results in increased expression of DDIT3 protein] |
CTD |
PMID:12414654 PMID:19819344 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DDIT4 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddit4l |
DNA-damage-inducible transcript 4-like |
increases expression |
ISO |
Vitamin K 3 results in increased expression of DDIT4L mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375
|
|
G |
Ddx1 |
DEAD-box helicase 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DDX1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:35,996,469...36,027,340
Ensembl chr 6:35,996,469...36,027,365
|
|
G |
Ddx23 |
DEAD-box helicase 23 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DDX23 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 7:129,797,620...129,814,909
Ensembl chr 7:129,797,614...129,814,949
|
|
G |
Ddx42 |
DEAD-box helicase 42 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of DDX42 mRNA |
CTD |
PMID:12414654 |
|
NCBI chr10:91,148,926...91,180,940
Ensembl chr10:91,148,254...91,180,939
|
|
G |
Ddx47 |
DEAD-box helicase 47 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DDX47 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:167,845,652...167,858,115
Ensembl chr 4:167,845,640...167,859,115
|
|
G |
Defb1 |
defensin beta 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DEFB1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604
|
|
G |
Depdc7 |
DEP domain containing 7 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DEPDC7 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:91,099,111...91,121,152
Ensembl chr 3:91,099,835...91,121,124
|
|
G |
Deptor |
DEP domain containing MTOR-interacting protein |
affects expression |
ISO |
Vitamin K 3 affects the expression of DEPTOR mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 7:86,514,859...86,668,817
Ensembl chr 7:86,514,988...86,667,773
|
|
G |
Desi2 |
desumoylating isopeptidase 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DESI2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr13:89,961,767...90,011,255
Ensembl chr13:89,961,934...90,016,416
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DGAT1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DGAT2 mRNA |
CTD |
PMID:20044591 PMID:23410634 |
|
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
|
|
G |
Dgkd |
diacylglycerol kinase, delta |
affects expression |
ISO |
Vitamin K 3 affects the expression of DGKD mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:88,516,686...88,607,349
Ensembl chr 9:88,516,715...88,607,345
|
|
G |
Dhrs11 |
dehydrogenase/reductase 11 |
increases reduction |
ISO |
DHRS11 protein results in increased reduction of Vitamin K 3 |
CTD |
PMID:30926317 |
|
NCBI chr10:69,698,214...69,708,294
Ensembl chr10:69,698,214...69,708,295
|
|
G |
Dhx35 |
DEAH-box helicase 35 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DHX35 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:147,450,178...147,507,473
Ensembl chr 3:147,450,163...147,507,451
|
|
G |
Dhx9 |
DExH-box helicase 9 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DHX9 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr13:65,602,322...65,639,098
Ensembl chr13:65,602,323...65,639,069
|
|
G |
Dipk1b |
divergent protein kinase domain 1B |
affects expression |
ISO |
Vitamin K 3 affects the expression of DIPK1B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:9,455,914...9,464,169
Ensembl chr 3:9,456,409...9,464,161
|
|
G |
Dkc1 |
dyskerin pseudouridine synthase 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DKC1 mRNA |
CTD |
PMID:20044591 |
|
|
|
G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
affects expression increases expression |
ISO |
Vitamin K 3 affects the expression of DKK1 mRNA Vitamin K 3 results in increased expression of DKK1 mRNA |
CTD |
PMID:12414654 PMID:20044591 |
|
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
|
|
G |
Dlgap5 |
DLG associated protein 5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DLGAP5 mRNA |
CTD |
PMID:20044591 PMID:23410634 |
|
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
|
|
G |
Dmd |
dystrophin |
increases response to substance |
ISO |
DMD gene mutant form results in increased susceptibility to Vitamin K 3 |
CTD |
PMID:10797403 |
|
NCBI chr X:47,272,324...49,504,219
Ensembl chr X:47,272,331...49,504,207
|
|
G |
Dmrt1 |
doublesex and mab-3 related transcription factor 1 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of DMRT1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:223,142,859...223,241,333
Ensembl chr 1:223,142,859...223,241,333
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DNAJB1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
|
|
G |
Dnajc14 |
DnaJ heat shock protein family (Hsp40) member C14 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DNAJC14 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 7:1,233,856...1,247,349
Ensembl chr 7:1,235,162...1,248,645
|
|
G |
Dnm1l |
dynamin 1-like |
affects expression |
ISO |
Vitamin K 3 affects the expression of DNM1L mRNA |
CTD |
PMID:20829426 |
|
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
affects expression |
ISO |
Vitamin K 3 affects the expression of DNMT3B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Dnmt3l |
DNA methyltransferase 3 like |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of DNMT3L mRNA |
CTD |
PMID:25270620 |
|
NCBI chr20:10,614,933...10,629,337
Ensembl chr20:10,614,934...10,629,516
|
|
G |
Dph1 |
diphthamide biosynthesis 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DPH1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:60,028,081...60,039,764
Ensembl chr10:60,026,048...60,039,850
|
|
G |
Dph3 |
diphthamide biosynthesis 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DPH3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr16:7,288,295...7,293,734
Ensembl chr16:7,282,705...7,291,265
|
|
G |
Dpm3 |
dolichyl-phosphate mannosyltransferase subunit 3, regulatory |
affects expression |
ISO |
Vitamin K 3 affects the expression of DPM3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:174,676,532...174,677,047
Ensembl chr 2:174,676,363...174,677,668 Ensembl chr15:174,676,363...174,677,668
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
affects expression |
ISO |
Vitamin K 3 affects the expression of DPYD mRNA |
CTD |
PMID:20829426 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
affects expression decreases expression |
ISO |
Vitamin K 3 affects the expression of DUSP1 mRNA Vitamin K 3 results in decreased expression of DUSP1 mRNA |
CTD |
PMID:23410634 PMID:25270620 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp2 |
dual specificity phosphatase 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DUSP2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:114,556,325...114,558,499
|
|
G |
Dusp3 |
dual specificity phosphatase 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DUSP3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:86,920,014...86,933,739
Ensembl chr10:86,920,014...86,933,962
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DUSP6 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dusp9 |
dual specificity phosphatase 9 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DUSP9 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr X:151,351,897...151,355,822
Ensembl chr X:151,351,897...151,355,821
|
|
G |
Dync1h1 |
dynein cytoplasmic 1 heavy chain 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DYNC1H1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:129,615,208...129,680,888
Ensembl chr 6:129,609,397...129,680,883
|
|
G |
Dync1li2 |
dynein, cytoplasmic 1 light intermediate chain 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DYNC1LI2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:531,783...554,670
Ensembl chr19:531,812...554,670
|
|
G |
Dyrk2 |
dual specificity tyrosine phosphorylation regulated kinase 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of DYRK2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 7:54,348,724...54,381,363
Ensembl chr 7:54,349,610...54,380,106
|
|
G |
E2f1 |
E2F transcription factor 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of E2F1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f3 |
E2F transcription factor 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of E2F3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253
|
|
G |
Ebna1bp2 |
EBNA1 binding protein 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of EBNA1BP2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:132,148,164...132,152,730
Ensembl chr 5:132,148,143...132,153,267
|
|
G |
Ecpas |
Ecm29 proteasome adaptor and scaffold |
affects expression |
ISO |
Vitamin K 3 affects the expression of ECPAS mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:73,601,745...73,714,026
Ensembl chr 5:73,604,533...73,713,860
|
|
G |
Edc3 |
enhancer of mRNA decapping 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of EDC3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:58,106,147...58,151,685
Ensembl chr 8:58,106,175...58,151,671
|
|
G |
Edn1 |
endothelin 1 |
increases expression affects expression |
ISO |
Vitamin K 3 results in increased expression of EDN1 mRNA Vitamin K 3 affects the expression of EDN1 mRNA |
CTD |
PMID:12414654 PMID:20044591 PMID:23410634 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Efnb2 |
ephrin B2 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of EFNB2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
|
|
G |
Egfr |
epidermal growth factor receptor |
increases phosphorylation |
EXP |
Vitamin K 3 results in increased phosphorylation of EGFR protein |
CTD |
PMID:15843167 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of EGLN3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Egr1 |
early growth response 1 |
increases expression affects expression |
ISO |
Vitamin K 3 results in increased expression of EGR1 mRNA Vitamin K 3 affects the expression of EGR1 mRNA |
CTD |
PMID:12414654 PMID:20044591 PMID:23410634 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Ehmt1 |
euchromatic histone lysine methyltransferase 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of EHMT1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:7,580,680...7,729,046
Ensembl chr 3:7,580,683...7,729,007
|
|
G |
Eif3c |
eukaryotic translation initiation factor 3, subunit C |
affects expression |
ISO |
Vitamin K 3 affects the expression of EIF3C mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:181,134,604...181,152,489
Ensembl chr 1:181,134,604...181,152,493
|
|
G |
Eif3j |
eukaryotic translation initiation factor 3, subunit J |
affects expression |
ISO |
Vitamin K 3 affects the expression of EIF3J mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:108,985,103...109,007,341
Ensembl chr 3:108,985,118...109,007,953
|
|
G |
Eif4a1 |
eukaryotic translation initiation factor 4A1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of EIF4A1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:54,384,345...54,389,855
Ensembl chr10:54,384,347...54,389,858
|
|
G |
Eif4b |
eukaryotic translation initiation factor 4B |
affects expression |
ISO |
Vitamin K 3 affects the expression of EIF4B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 7:133,206,637...133,228,436
|
|
G |
Eif4enif1 |
eukaryotic translation initiation factor 4E nuclear import factor 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of EIF4ENIF1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr14:78,056,115...78,099,846
Ensembl chr14:78,056,297...78,098,793
|
|
G |
Eif4g2 |
eukaryotic translation initiation factor 4, gamma 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of EIF4G2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:165,181,433...165,193,583
Ensembl chr 1:165,181,434...165,193,588
|
|
G |
Elavl1 |
ELAV like RNA binding protein 1 |
multiple interactions increases phosphorylation |
ISO |
[[Vitamin K 3 results in increased phosphorylation of JAK3 protein] which results in increased phosphorylation of and affects the localization of ELAVL1 protein] inhibits the reaction [ELAVL1 protein binds to and results in decreased degradation of SIRT1 mRNA]; [[Vitamin K 3 results in increased phosphorylation of JAK3 protein] which results in increased phosphorylation of and affects the localization of ELAVL1 protein] inhibits the reaction [ELAVL1 protein binds to and results in decreased degradation of VHL mRNA]; [Vitamin K 3 results in increased phosphorylation of JAK3 protein] which results in increased phosphorylation of and affects the localization of ELAVL1 protein; JAK3 protein promotes the reaction [Vitamin K 3 results in increased phosphorylation of ELAVL1 protein]; Janus Kinase Inhibitors inhibits the reaction [Vitamin K 3 results in increased phosphorylation of ELAVL1 protein]; Vitamin K 3 inhibits the reaction [sodium arsenite promotes the reaction [ELAVL1 protein binds to and results in decreased degradation of SIRT1 mRNA]]; Vitamin K 3 inhibits the reaction [sodium arsenite promotes the reaction [ELAVL1 protein binds to and results in decreased degradation of VHL mRNA]] |
CTD |
PMID:24106086 |
|
NCBI chr12:2,640,936...2,684,787
Ensembl chr12:2,645,061...2,684,784
|
|
G |
Elavl2 |
ELAV like RNA binding protein 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ELAVL2 mRNA |
CTD |
PMID:20829426 |
|
NCBI chr 5:105,960,872...106,086,463
Ensembl chr 5:105,960,875...106,109,097
|
|
G |
Elof1 |
elongation factor 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ELOF1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:20,645,336...20,650,888
Ensembl chr 8:20,645,336...20,650,579
|
|
G |
Emg1 |
EMG1 N1-specific pseudouridine methyltransferase |
affects expression |
ISO |
Vitamin K 3 affects the expression of EMG1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:157,509,258...157,517,540
Ensembl chr 4:157,509,277...157,517,540
|
|
G |
Emilin1 |
elastin microfibril interfacer 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of EMILIN1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 6:25,455,974...25,463,713
Ensembl chr 6:25,445,298...25,463,698
|
|
G |
Emp2 |
epithelial membrane protein 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of EMP2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:5,360,073...5,394,734
Ensembl chr10:5,360,073...5,394,733
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ENC1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
|
|
G |
Enosf1 |
enolase superfamily member 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ENOSF1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:113,275,267...113,314,842
|
|
G |
Enpp3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of ENPP3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:20,563,700...20,635,044
Ensembl chr 1:20,563,697...20,635,041
|
|
G |
Ep300 |
E1A binding protein p300 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of EP300 protein |
CTD |
PMID:31238027 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of EPAS1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of EPHX1 mRNA |
CTD |
PMID:21382384 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Epn2 |
epsin 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of EPN2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:46,197,785...46,259,673
Ensembl chr10:46,197,785...46,259,642
|
|
G |
Epn3 |
epsin 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of EPN3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:79,438,978...79,449,516
Ensembl chr10:79,438,978...79,447,356
|
|
G |
Epo |
erythropoietin |
multiple interactions |
ISO |
[Vitamin K 3 results in increased abundance of Hydrogen Peroxide] which results in decreased expression of EPO protein |
CTD |
PMID:7980410 |
|
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Eprs1 |
glutamyl-prolyl-tRNA synthetase 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of EPRS1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
|
|
G |
Eps8l2 |
EPS8-like 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of EPS8L2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:196,446,260...196,471,544
Ensembl chr 1:196,446,287...196,471,541
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ERBB3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Erbin |
erbb2 interacting protein |
affects expression |
ISO |
Vitamin K 3 affects the expression of ERBIN mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:34,926,962...35,028,440
Ensembl chr 2:34,928,863...35,027,852
|
|
G |
Esr1 |
estrogen receptor 1 |
affects binding multiple interactions |
ISO |
Vitamin K 3 binds to ESR1 protein Vitamin K 3 inhibits the reaction [Estradiol binds to ESR1 protein] |
CTD |
PMID:15081572 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esrp1 |
epithelial splicing regulatory protein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ESRP1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:24,427,611...24,482,157
Ensembl chr 5:24,428,717...24,482,062
|
|
G |
Esrp2 |
epithelial splicing regulatory protein 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ESRP2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:34,034,559...34,041,726
Ensembl chr19:34,034,559...34,041,726
|
|
G |
Esyt2 |
extended synaptotagmin 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ESYT2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:137,219,653...137,312,590
Ensembl chr 6:137,219,707...137,312,590
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
affects expression |
ISO |
Vitamin K 3 affects the expression of ETS2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
|
|
G |
Exosc10 |
exosome component 10 |
affects expression |
ISO |
Vitamin K 3 affects the expression of EXOSC10 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:158,995,313...159,018,940
Ensembl chr 5:158,995,313...159,018,940
|
|
G |
Exosc8 |
exosome component 8 |
affects expression |
ISO |
Vitamin K 3 affects the expression of EXOSC8 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:138,930,405...138,937,009
Ensembl chr 2:138,930,405...138,936,928
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
affects expression |
ISO |
Vitamin K 3 affects the expression of EZH2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
|
|
G |
Ezr |
ezrin |
affects expression |
ISO |
Vitamin K 3 affects the expression of EZR mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
|
|
G |
F10 |
coagulation factor X |
multiple interactions |
EXP |
Vitamin K 3 inhibits the reaction [Ethyl Biscoumacetate results in decreased expression of F10 protein] |
CTD |
PMID:6768192 |
|
NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
|
|
G |
F2rl1 |
F2R like trypsin receptor 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of F2RL1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226
|
|
G |
F8a1 |
coagulation factor VIII-associated 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of F8A1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr X:150,957,357...150,958,871
Ensembl chr X:150,916,679...150,960,168
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FABP1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
Faf1 |
Fas associated factor 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FAF1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:124,426,032...124,790,014
Ensembl chr 5:124,426,062...124,789,977
|
|
G |
Fam107b |
family with sequence similarity 107, member B |
affects expression |
ISO |
Vitamin K 3 affects the expression of FAM107B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:74,478,608...74,685,027
Ensembl chr17:74,478,608...74,684,989
|
|
G |
Fam111a |
FAM111 trypsin like peptidase A |
affects expression |
ISO |
Vitamin K 3 affects the expression of FAM111A mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:209,640,865...209,656,551
Ensembl chr 1:209,640,953...209,656,547
|
|
G |
Fam174b |
family with sequence similarity 174, member B |
affects expression |
ISO |
Vitamin K 3 affects the expression of FAM174B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:127,515,393...127,618,591
Ensembl chr 1:127,514,041...127,596,128 Ensembl chr 1:127,514,041...127,596,128
|
|
G |
Fam20c |
FAM20C, golgi associated secretory pathway kinase |
affects expression |
ISO |
Vitamin K 3 affects the expression of FAM20C mRNA |
CTD |
PMID:20044591 |
|
NCBI chr12:15,826,864...15,885,423
Ensembl chr12:15,826,871...15,884,543
|
|
G |
Fam217b |
family with sequence similarity 217, member B |
affects expression |
ISO |
Vitamin K 3 affects the expression of FAM217B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:165,505,574...165,515,273
Ensembl chr 3:165,501,532...165,513,377
|
|
G |
Fam222b |
family with sequence similarity 222, member B |
affects expression |
ISO |
Vitamin K 3 affects the expression of FAM222B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:62,986,571...63,052,350
Ensembl chr10:62,986,571...63,052,350
|
|
G |
Fam241b |
family with sequence similarity 241 member B |
affects expression |
ISO |
Vitamin K 3 affects the expression of FAM241B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr20:30,052,315...30,055,247
Ensembl chr20:30,052,324...30,055,084
|
|
G |
Fam89b |
family with sequence similarity 89, member B |
affects expression |
ISO |
Vitamin K 3 affects the expression of FAM89B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:203,015,772...203,017,890
Ensembl chr 1:203,015,773...203,017,367
|
|
G |
Fanca |
FA complementation group A |
affects expression |
ISO |
Vitamin K 3 affects the expression of FANCA mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:51,304,126...51,362,586
Ensembl chr19:51,304,021...51,362,527
|
|
G |
Fancf |
FA complementation group F |
affects expression |
ISO |
Vitamin K 3 affects the expression of FANCF mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:101,449,120...101,451,936
Ensembl chr 1:101,450,389...101,451,923
|
|
G |
Farp1 |
FERM, ARH/RhoGEF and pleckstrin domain protein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FARP1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr15:98,124,304...98,363,299
Ensembl chr15:98,182,329...98,363,299
|
|
G |
Farsb |
phenylalanyl-tRNA synthetase subunit beta |
affects expression |
ISO |
Vitamin K 3 affects the expression of FARSB mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:79,887,852...79,947,082
Ensembl chr 9:79,887,842...79,947,045
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
Vitamin K 3 results in increased expression of FAS mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faxdc2 |
fatty acid hydroxylase domain containing 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FAXDC2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:42,245,808...42,271,679
Ensembl chr10:42,246,868...42,271,871
|
|
G |
Fbln1 |
fibulin 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FBLN1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
|
|
G |
Fbxl15 |
F-box and leucine-rich repeat protein 15 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FBXL15 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:245,189,732...245,191,973
Ensembl chr 1:245,189,736...245,192,007
|
|
G |
Fbxl16 |
F-box and leucine-rich repeat protein 16 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FBXL16 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:14,829,453...14,841,739
Ensembl chr10:14,829,449...14,840,986
|
|
G |
Fbxo11 |
F-box protein 11 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FBXO11 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:6,486,761...6,562,664
Ensembl chr 6:6,486,015...6,562,662
|
|
G |
Fbxo21 |
F-box protein 21 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FBXO21 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr12:38,570,878...38,605,133
Ensembl chr12:38,571,023...38,605,133
|
|
G |
Fbxo30 |
F-box protein 30 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of FBXO30 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 1:5,655,341...5,671,558
Ensembl chr 1:5,655,339...5,672,441
|
|
G |
Fcgr2b |
Fc gamma receptor 2B |
affects expression |
ISO |
Vitamin K 3 affects the expression of FCGR2B mRNA |
CTD |
PMID:20829426 |
|
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
|
|
G |
Fcsk |
fucose kinase |
affects expression |
ISO |
Vitamin K 3 affects the expression of FCSK mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:38,849,130...38,874,497
Ensembl chr19:38,854,762...38,874,418
|
|
G |
Fdxr |
ferredoxin reductase |
affects expression increases expression |
ISO |
Vitamin K 3 affects the expression of FDXR mRNA Vitamin K 3 results in increased expression of FDXR mRNA |
CTD |
PMID:12414654 PMID:20044591 |
|
NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658
|
|
G |
Fen1 |
flap structure-specific endonuclease 1 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of FEN1 mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
|
|
G |
Fermt1 |
FERM domain containing kindlin 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FERMT1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:120,171,301...120,213,555
Ensembl chr 3:120,171,561...120,213,555
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FGFR2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fgg |
fibrinogen gamma chain |
increases expression affects expression |
ISO |
Vitamin K 3 results in increased expression of FGG mRNA Vitamin K 3 affects the expression of FGG mRNA |
CTD |
PMID:12414654 PMID:20044591 |
|
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
increases response to substance |
ISO |
FHIT protein results in increased susceptibility to Vitamin K 3 |
CTD |
PMID:19622739 |
|
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G |
Fhl2 |
four and a half LIM domains 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FHL2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192
|
|
G |
Fibp |
FGF1 intracellular binding protein |
affects expression |
ISO |
Vitamin K 3 affects the expression of FIBP mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:202,768,065...202,772,405
Ensembl chr 1:202,768,078...202,772,399
|
|
G |
Fip1l1 |
factor interacting with PAPOLA and CPSF1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FIP1L1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr14:33,615,210...33,675,742
Ensembl chr14:33,617,720...33,675,708
|
|
G |
Fkbp9 |
FKBP prolyl isomerase 9 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FKBP9 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:86,106,256...86,156,723
Ensembl chr 4:86,106,282...86,156,721
|
|
G |
Flcn |
folliculin |
affects expression |
ISO |
Vitamin K 3 affects the expression of FLCN mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:44,588,621...44,607,808
Ensembl chr10:44,588,624...44,607,769
|
|
G |
Flnb |
filamin B |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of FLNB mRNA |
CTD |
PMID:25270620 |
|
NCBI chr15:16,961,999...17,095,059
Ensembl chr15:16,962,003...17,095,006
|
|
G |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FLRT3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:127,994,491...128,008,137
Ensembl chr 3:127,994,226...128,007,841
|
|
G |
Flvcr1 |
FLVCR choline and heme transporter 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FLVCR1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr13:102,586,263...102,608,647
Ensembl chr13:102,586,257...102,608,661
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FMR1 mRNA |
CTD |
PMID:20829426 |
|
NCBI chr X:147,240,239...147,278,057
Ensembl chr X:147,240,301...147,278,050
|
|
G |
Fn3krp |
fructosamine-3-kinase-related protein |
affects expression |
ISO |
Vitamin K 3 affects the expression of FN3KRP mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:106,688,413...106,697,137
Ensembl chr10:106,688,439...106,697,134
|
|
G |
Fndc3a |
fibronectin type III domain containing 3a |
affects expression |
ISO |
Vitamin K 3 affects the expression of FNDC3A mRNA |
CTD |
PMID:20044591 |
|
NCBI chr15:47,689,909...47,867,354
Ensembl chr15:47,689,919...47,866,784
|
|
G |
Focad |
focadhesin |
affects expression |
ISO |
Vitamin K 3 affects the expression of FOCAD mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:102,564,560...102,886,587
Ensembl chr 5:102,564,598...102,886,582
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Vitamin K 3 analog results in increased expression of FOS mRNA; Vitamin K 3 results in increased expression of FOS mRNA |
CTD |
PMID:19273458 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxa1 |
forkhead box A1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FOXA1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
|
|
G |
Foxa3 |
forkhead box A3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FOXA3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:78,662,067...78,672,321
Ensembl chr 1:78,662,431...78,672,155
|
|
G |
Foxc1 |
forkhead box C1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FOXC1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:32,631,379...32,635,361
Ensembl chr17:32,633,142...32,634,803
|
|
G |
Foxd2 |
forkhead box D2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FOXD2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:128,427,986...128,430,709
Ensembl chr 5:128,429,020...128,430,504
|
|
G |
Foxj3 |
forkhead box J3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FOXJ3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:133,140,344...133,228,489
Ensembl chr 5:133,140,884...133,228,489
|
|
G |
Foxm1 |
forkhead box M1 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of FOXM1 mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
|
|
G |
Foxp1 |
forkhead box P1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FOXP1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
|
|
G |
Frmd4a |
FERM domain containing 4A |
affects expression |
ISO |
Vitamin K 3 affects the expression of FRMD4A mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:73,667,787...74,258,487
Ensembl chr17:73,667,789...74,258,687
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions |
EXP |
Vitamin K 3 results in decreased expression of and results in decreased secretion of FSHB protein |
CTD |
PMID:30536483 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Ftl1 |
ferritin light chain 1 |
affects expression multiple interactions increases expression |
ISO |
Vitamin K 3 affects the expression of FTL mRNA Vitamin K 3 promotes the reaction [Iron binds to [FTL protein binds to FTMT protein]] Vitamin K 3 results in increased expression of FTL mRNA |
CTD |
PMID:12414654 PMID:12644586 PMID:20044591 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
|
|
G |
Ftmt |
ferritin mitochondrial |
multiple interactions |
ISO |
Vitamin K 3 promotes the reaction [Iron binds to [FTL protein binds to FTMT protein]] |
CTD |
PMID:12644586 |
|
NCBI chr18:45,758,874...45,760,123
Ensembl chr18:45,758,874...45,760,123
|
|
G |
Fuom |
fucose mutarotase |
affects expression |
ISO |
Vitamin K 3 affects the expression of FUOM mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:194,888,535...194,893,046
Ensembl chr 1:194,886,709...194,893,046
|
|
G |
Fut1 |
fucosyltransferase 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FUT1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:96,086,934...96,090,352
Ensembl chr 1:96,086,635...96,090,616
|
|
G |
Fut8 |
fucosyltransferase 8 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FUT8 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:95,949,246...96,176,677
Ensembl chr 6:95,949,991...96,176,677
|
|
G |
Fzd4 |
frizzled class receptor 4 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FZD4 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:143,279,934...143,288,799
Ensembl chr 1:143,280,065...143,285,724
|
|
G |
Fzd7 |
frizzled class receptor 7 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FZD7 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
|
|
G |
G0s2 |
G0/G1switch 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of G0S2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
|
|
G |
G2e3 |
G2/M-phase specific E3 ubiquitin protein ligase |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of G2E3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 6:68,763,847...68,795,305
Ensembl chr 6:68,764,185...68,793,924
|
|
G |
Gaa |
alpha glucosidase |
affects expression |
ISO |
Vitamin K 3 affects the expression of GAA mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:104,529,673...104,546,836
Ensembl chr10:104,529,747...104,546,836
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
affects expression |
ISO |
Vitamin K 3 affects the expression of GADD45B mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gal |
galanin and GMAP prepropeptide |
affects expression |
ISO |
Vitamin K 3 affects the expression of GAL mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
|
|
G |
Gal3st1 |
galactose-3-O-sulfotransferase 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GAL3ST1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr14:78,868,049...78,886,402
Ensembl chr14:78,870,793...78,886,388
|
|
G |
Galm |
galactose mutarotase |
affects expression |
ISO |
Vitamin K 3 affects the expression of GALM mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:14,837,540...14,889,484
Ensembl chr 6:14,837,548...14,889,310
|
|
G |
Galnt11 |
polypeptide N-acetylgalactosaminyltransferase 11 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GALNT11 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:9,837,629...9,871,141
Ensembl chr 4:9,837,629...9,871,140
|
|
G |
Gap43 |
growth associated protein 43 |
increases expression |
ISO |
Vitamin K 3 analog results in increased expression of GAP43 mRNA |
CTD |
PMID:19273458 |
|
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
|
|
G |
Gart |
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase |
affects expression |
ISO |
Vitamin K 3 affects the expression of GART mRNA |
CTD |
PMID:20044591 |
|
NCBI chr11:30,864,896...30,891,125
Ensembl chr11:30,865,889...30,891,125
|
|
G |
Gata6 |
GATA binding protein 6 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GATA6 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr18:2,188,121...2,219,532
Ensembl chr18:2,188,121...2,219,532
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases activity multiple interactions increases expression |
ISO |
Vitamin K 3 results in increased activity of GCLC protein Dactinomycin inhibits the reaction [Vitamin K 3 results in increased expression of GCLC mRNA] |
CTD |
PMID:11972604 PMID:23410634 PMID:25270620 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
Vitamin K 3 results in increased expression of GCLM mRNA |
CTD |
PMID:12414654 PMID:23410634 PMID:25270620 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
increases expression |
ISO |
Vitamin K 3 results in increased expression of GCNT3 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
|
|
G |
Gdf15 |
growth differentiation factor 15 |
affects expression increases expression |
ISO |
Vitamin K 3 affects the expression of GDF15 mRNA Vitamin K 3 results in increased expression of GDF15 mRNA |
CTD |
PMID:12414654 PMID:20044591 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gdi1 |
GDP dissociation inhibitor 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GDI1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr X:152,087,611...152,094,274
Ensembl chr X:152,087,444...152,094,272
|
|
G |
Gdi2 |
GDP dissociation inhibitor 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GDI2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:66,649,616...66,676,299
Ensembl chr17:66,649,619...66,676,366
|
|
G |
Gdpd5 |
glycerophosphodiester phosphodiesterase domain containing 5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GDPD5 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 1:153,679,718...153,761,452
Ensembl chr 1:153,679,718...153,761,446
|
|
G |
Gemin6 |
gem (nuclear organelle) associated protein 6 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GEMIN6 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:14,786,090...14,790,617
Ensembl chr 6:14,786,070...14,790,612
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
decreases expression multiple interactions |
EXP |
Vitamin K 3 results in decreased expression of GGT1 mRNA alternative form Acetylcysteine inhibits the reaction [Vitamin K 3 results in increased activity of GGT1 protein]; Vitamin K 3 results in increased expression of and results in increased activity of GGT1 protein |
CTD |
PMID:12030384 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Ghr |
growth hormone receptor |
affects expression |
ISO |
Vitamin K 3 affects the expression of GHR mRNA |
CTD |
PMID:20829426 |
|
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
|
|
G |
Gigyf2 |
GRB10 interacting GYF protein 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GIGYF2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:88,001,212...88,127,040
Ensembl chr 9:88,001,301...88,125,715
|
|
G |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of GIPC2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:241,030,764...241,110,236
Ensembl chr 2:241,030,770...241,110,236
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GJA1 mRNA |
CTD |
PMID:20829426 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Glcci1 |
glucocorticoid induced 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GLCCI1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:36,307,956...36,635,614
Ensembl chr 4:36,307,903...36,635,612
|
|
G |
Gldc |
glycine decarboxylase |
affects expression |
ISO |
Vitamin K 3 affects the expression of GLDC mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:227,883,249...227,962,119
Ensembl chr 1:227,883,249...227,962,097
|
|
G |
Glg1 |
golgi glycoprotein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GLG1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:39,124,892...39,224,178
Ensembl chr19:39,124,641...39,224,178
|
|
G |
Glrx |
glutaredoxin |
increases expression |
ISO |
Vitamin K 3 results in increased expression of GLRX mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
|
|
G |
Gls |
glutaminase |
affects expression |
ISO |
Vitamin K 3 affects the expression of GLS mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
|
|
G |
Glt8d1 |
glycosyltransferase 8 domain containing 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GLT8D1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr16:6,192,269...6,207,227
Ensembl chr16:6,192,300...6,207,229
|
|
G |
Glyctk |
glycerate kinase |
affects expression |
ISO |
Vitamin K 3 affects the expression of GLYCTK mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:106,795,461...106,802,675
Ensembl chr 8:106,797,343...106,802,397
|
|
G |
Gnai1 |
G protein subunit alpha i1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GNAI1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 4:16,814,000...16,898,119
Ensembl chr 4:16,814,001...16,896,417
|
|
G |
Gnaz |
G protein subunit alpha z |
affects expression |
ISO |
Vitamin K 3 affects the expression of GNAZ mRNA |
CTD |
PMID:20044591 |
|
NCBI chr20:13,643,473...13,694,240
Ensembl chr20:13,644,640...13,669,907
|
|
G |
Gnpat |
glyceronephosphate O-acyltransferase |
affects expression |
ISO |
Vitamin K 3 affects the expression of GNPAT mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:52,822,326...52,848,872
Ensembl chr19:52,822,319...52,852,361
|
|
G |
Golga3 |
golgin A3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GOLGA3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr12:46,452,409...46,500,509
Ensembl chr12:46,454,870...46,500,509
|
|
G |
Gon4l |
gon-4 like |
affects expression |
ISO |
Vitamin K 3 affects the expression of GON4L mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:174,233,461...174,306,636
Ensembl chr 2:174,233,461...174,306,634
|
|
G |
Gopc |
golgi associated PDZ and coiled-coil motif containing |
affects expression |
ISO |
Vitamin K 3 affects the expression of GOPC mRNA |
CTD |
PMID:20044591 |
|
NCBI chr20:31,727,617...31,776,904
Ensembl chr20:31,727,620...31,776,903
|
|
G |
Gpank1 |
G patch domain and ankyrin repeats 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GPANK1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr20:3,697,641...3,700,814
Ensembl chr20:3,697,641...3,700,858
|
|
G |
Gpat3 |
glycerol-3-phosphate acyltransferase 3 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of GPAT3 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
|
|
G |
Gpbp1 |
GC-rich promoter binding protein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GPBP1 mRNA |
CTD |
PMID:20829426 |
|
NCBI chr 2:43,023,504...43,091,146
Ensembl chr 2:43,023,504...43,090,907
|
|
G |
Gpr160 |
G protein-coupled receptor 160 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GPR160 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:112,483,364...112,563,072
Ensembl chr 2:112,484,935...112,563,148
|
|
G |
Gprc5a |
G protein-coupled receptor, class C, group 5, member A |
affects expression |
ISO |
Vitamin K 3 affects the expression of GPRC5A mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:167,903,542...167,922,276
Ensembl chr 4:167,903,542...167,922,260
|
|
G |
Gprc5b |
G protein-coupled receptor, class C, group 5, member B |
affects expression |
ISO |
Vitamin K 3 affects the expression of GPRC5B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:173,316,904...173,340,933
Ensembl chr 1:173,316,907...173,340,932
|
|
G |
Gprc5c |
G protein-coupled receptor, class C, group 5, member C |
affects expression |
ISO |
Vitamin K 3 affects the expression of GPRC5C mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:99,886,900...99,908,928
Ensembl chr10:99,887,077...99,908,926
|
|
G |
Gpt2 |
glutamic--pyruvic transaminase 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GPT2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:21,526,800...21,561,314
Ensembl chr19:21,517,621...21,560,610
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
decreases response to substance |
ISO |
GPX1 protein results in decreased susceptibility to Vitamin K 3 |
CTD |
PMID:1939125 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of GPX2 mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Grid1 |
glutamate ionotropic receptor delta type subunit 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GRID1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr16:10,138,564...10,885,803
Ensembl chr16:10,138,925...10,885,808
|
|
G |
Grin2c |
glutamate ionotropic receptor NMDA type subunit 2C |
increases expression |
ISO |
Vitamin K 3 results in increased expression of GRIN2C mRNA |
CTD |
PMID:12414654 |
|
NCBI chr10:100,488,430...100,507,083
Ensembl chr10:100,488,431...100,506,427
|
|
G |
Grk5 |
G protein-coupled receptor kinase 5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GRK5 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:260,028,269...260,223,699
Ensembl chr 1:260,028,242...260,218,701
|
|
G |
Grn |
granulin precursor |
affects expression |
ISO |
Vitamin K 3 affects the expression of GRN mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
|
|
G |
Grwd1 |
glutamate-rich WD repeat containing 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GRWD1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:96,301,260...96,306,962
Ensembl chr 1:96,301,261...96,307,201
|
|
G |
Gsdme |
gasdermin E |
affects expression |
ISO |
Vitamin K 3 affects the expression of GSDME mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:79,258,799...79,321,129
Ensembl chr 4:79,257,804...79,320,806
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
increases expression |
ISO |
Vitamin K 3 results in increased expression of GSK3B protein |
CTD |
PMID:31238027 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsn |
gelsolin |
affects response to substance |
ISO |
GSN mRNA affects the susceptibility to Vitamin K 3 |
CTD |
PMID:14652020 PMID:15033777 |
|
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
ISO |
Vitamin K 3 results in increased expression of GSR mRNA |
CTD |
PMID:23410634 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GSTA1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GSTA2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GSTA4 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GSTA5 mRNA |
CTD |
PMID:20044591 PMID:20829426 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of GSTM1 mRNA |
CTD |
PMID:14610226 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GSTO1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468
|
|
G |
Gtf2i |
general transcription factor II I |
affects expression |
ISO |
Vitamin K 3 affects the expression of GTF2I mRNA |
CTD |
PMID:20044591 |
|
NCBI chr12:22,400,933...22,476,243
Ensembl chr12:22,401,431...22,476,243
|
|
G |
Gtf3c2 |
general transcription factor IIIC subunit 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GTF3C2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:25,196,439...25,221,338
Ensembl chr 6:25,197,268...25,220,490
|
|
G |
Gtpbp3 |
GTP binding protein 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GTPBP3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr16:18,175,766...18,180,857
Ensembl chr16:18,175,766...18,180,857
|
|
G |
Gtpbp4 |
GTP binding protein 4 |
affects expression |
ISO |
Vitamin K 3 affects the expression of GTPBP4 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:61,308,033...61,328,184
Ensembl chr17:61,308,014...61,418,009
|
|
G |
Gucy1a1 |
guanylate cyclase 1 soluble subunit alpha 1 |
decreases expression |
EXP |
Vitamin K 3 results in decreased expression of GUCY1A1 protein |
CTD |
PMID:17339839 |
|
NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671
|
|
G |
Gucy1b1 |
guanylate cyclase 1 soluble subunit beta 1 |
decreases expression |
EXP |
Vitamin K 3 results in decreased expression of GUCY1B1 protein |
CTD |
PMID:17339839 |
|
NCBI chr 2:167,348,824...167,398,983
Ensembl chr 2:167,348,825...167,398,916
|
|
G |
Gucy2c |
guanylate cyclase 2C |
affects expression |
ISO |
Vitamin K 3 affects the expression of GUCY2C mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:169,568,505...169,649,092
Ensembl chr 4:169,568,529...169,649,092
|
|
G |
Gusb |
glucuronidase, beta |
affects expression |
ISO |
Vitamin K 3 affects the expression of GUSB mRNA |
CTD |
PMID:20044591 |
|
NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905
|
|
G |
H1f4 |
H1.4 linker histone, cluster member |
affects expression |
ISO |
Vitamin K 3 affects the expression of H1-4 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:41,486,574...41,487,355
Ensembl chr17:41,486,560...41,487,403
|
|
G |
H1f5 |
H1.5 linker histone, cluster member |
affects expression |
ISO |
Vitamin K 3 affects the expression of H1-5 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:42,726,132...42,727,162
Ensembl chr17:42,726,127...42,769,160
|
|
G |
H2ac18 |
H2A clustered histone 18 |
affects expression |
ISO |
Vitamin K 3 affects the expression of H2AC18 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:183,808,398...183,808,992
|
|
G |
H2ac20 |
H2A clustered histone 20 |
affects expression |
ISO |
Vitamin K 3 affects the expression of H2AC20 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:183,779,879...183,780,357
|
|
G |
H2ac25 |
H2A clustered histone 25 |
affects expression |
ISO |
Vitamin K 3 affects the expression of H2AC25 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:43,733,702...43,735,254
Ensembl chr10:43,733,668...43,744,874
|
|
G |
H2aj |
H2A.J histone |
affects expression |
ISO |
Vitamin K 3 affects the expression of H2AJ mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:169,675,718...169,676,202
Ensembl chr 4:169,675,752...169,677,006
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions |
ISO |
[Ascorbic Acid results in increased reduction of Vitamin K 3] which results in increased phosphorylation of H2AX protein |
CTD |
PMID:19482829 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
H2bc3 |
H2B clustered histone 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of H2BC3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:41,380,056...41,380,686
|
|
G |
H2bc6 |
H2B clustered histone 6 |
affects expression |
ISO |
Vitamin K 3 affects the expression of H2BC6 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:41,520,775...41,521,238
|
|
G |
H2bc9 |
H2B clustered histone 9 |
affects expression |
ISO |
Vitamin K 3 affects the expression of H2BC9 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:42,470,593...42,478,590
|
|
G |
H2bu1 |
H2B.U histone 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of H2BC26 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:43,732,737...43,733,484
Ensembl chr10:43,732,864...43,736,277
|
|
G |
Hadh |
hydroxyacyl-CoA dehydrogenase |
affects expression |
ISO |
Vitamin K 3 affects the expression of HADH mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
affects expression |
ISO |
Vitamin K 3 affects the expression of HAMP mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
|
|
G |
Hars2 |
histidyl-tRNA synthetase 2, mitochondrial |
affects expression |
ISO |
Vitamin K 3 affects the expression of HARS2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr18:28,398,790...28,408,075
Ensembl chr18:28,398,795...28,414,747
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HAVCR1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hba-a3 |
hemoglobin alpha, adult chain 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HBA2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:15,311,637...15,312,481
Ensembl chr10:15,311,634...15,312,481
|
|
G |
Hbp1 |
HMG-box transcription factor 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HBP1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:48,529,633...48,555,775
Ensembl chr 6:48,529,372...48,555,787
|
|
G |
Hcar1 |
hydroxycarboxylic acid receptor 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HCAR1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr12:32,710,680...32,713,934
Ensembl chr12:32,711,027...32,712,082
|
|
G |
Hccs |
holocytochrome c synthase |
affects expression |
ISO |
Vitamin K 3 affects the expression of HCCS mRNA |
CTD |
PMID:20044591 |
|
NCBI chr X:24,932,943...24,942,376
Ensembl chr X:24,933,002...24,942,366
|
|
G |
Hcfc1r1 |
host cell factor C1 regulator 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HCFC1R1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:12,705,139...12,706,852
Ensembl chr10:12,705,077...12,706,850
|
|
G |
Hdac11 |
histone deacetylase 11 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HDAC11 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 4:123,645,873...123,667,407
Ensembl chr 4:123,650,157...123,667,405
|
|
G |
Hdac2 |
histone deacetylase 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HDAC2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
|
|
G |
Heatr1 |
HEAT repeat containing 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HEATR1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:58,053,288...58,093,895
Ensembl chr17:58,051,700...58,093,948
|
|
G |
Heca |
hdc homolog, cell cycle regulator |
affects expression |
ISO |
Vitamin K 3 affects the expression of HECA mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:12,525,445...12,575,358
Ensembl chr 1:12,525,135...12,576,427
|
|
G |
Heph |
hephaestin |
affects expression |
ISO |
Vitamin K 3 affects the expression of HEPH mRNA |
CTD |
PMID:20044591 |
|
NCBI chr X:61,151,131...61,402,980
Ensembl chr X:61,296,345...61,402,980
|
|
G |
Herc2 |
HECT and RLD domain containing E3 ubiquitin protein ligase 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HERC2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:106,904,789...107,110,997
Ensembl chr 1:106,880,084...107,108,134
|
|
G |
Herpud1 |
homocysteine inducible ER protein with ubiquitin like domain 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HERPUD1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
affects expression multiple interactions increases expression |
ISO |
Vitamin K 3 affects the expression of HES1 mRNA EUK-134 inhibits the reaction [Vitamin K 3 results in increased expression of HES1 protein] |
CTD |
PMID:20044591 PMID:25005833 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hes6 |
hes family bHLH transcription factor 6 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HES6 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 9:92,001,849...92,003,562
Ensembl chr 9:92,001,841...92,003,559
|
|
G |
Hgsnat |
heparan-alpha-glucosaminide N-acetyltransferase |
affects expression |
ISO |
Vitamin K 3 affects the expression of HGSNAT mRNA |
CTD |
PMID:20044591 |
|
NCBI chr16:66,105,233...66,137,444
Ensembl chr16:66,105,181...66,136,138
|
|
G |
Hibadh |
3-hydroxyisobutyrate dehydrogenase |
affects expression |
ISO |
Vitamin K 3 affects the expression of HIBADH mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:81,649,180...81,747,244
Ensembl chr 4:81,649,175...81,780,617
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
increases expression multiple interactions |
ISO EXP |
Vitamin K 3 results in increased expression of HIF1A mRNA; Vitamin K 3 results in increased expression of HIF1A protein Vitamin K 3 inhibits the reaction [carbobenzoxy-leucyl-leucyl-leucine results in increased expression of HIF1A protein]; Vitamin K 3 inhibits the reaction [cobaltous chloride results in increased expression of HIF1A protein]; Vitamin K 3 inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein] |
CTD |
PMID:12595275 PMID:16507596 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hif3a |
hypoxia inducible factor 3 subunit alpha |
affects expression |
ISO |
Vitamin K 3 affects the expression of HIF3A mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:77,718,110...77,750,448
Ensembl chr 1:77,722,471...77,749,758
|
|
G |
Hipk2 |
homeodomain interacting protein kinase 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HIPK2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:67,439,327...67,619,223
Ensembl chr 4:67,440,501...67,619,223
|
|
G |
Hist1h2af |
histone cluster 1 H2A family member F |
affects expression |
ISO |
Vitamin K 3 affects the expression of H2AC8 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:41,379,404...41,379,796
Ensembl chr17:41,379,404...41,379,796
|
|
G |
Hist1h2bq |
histone cluster 1 H2B family member Q |
affects expression |
ISO |
Vitamin K 3 affects the expression of H2BC7 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:41,432,100...41,441,487
Ensembl chr17:41,429,164...41,442,153
|
|
G |
Hist1h4m |
histone cluster 1, H4m |
affects expression |
ISO |
Vitamin K 3 affects the expression of H4C1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:42,698,016...42,698,420
Ensembl chr17:42,698,025...42,698,958
|
|
G |
Hlcs |
holocarboxylase synthetase |
affects expression |
ISO |
Vitamin K 3 affects the expression of HLCS mRNA |
CTD |
PMID:20044591 |
|
NCBI chr11:33,455,806...33,635,197
Ensembl chr11:33,455,809...33,624,222
|
|
G |
Hmbox1 |
homeobox containing 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HMBOX1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr15:39,067,805...39,200,633
Ensembl chr15:39,067,804...39,200,323
|
|
G |
Hmgb3 |
high mobility group box 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HMGB3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr X:149,296,303...149,301,290
Ensembl chr X:149,296,375...149,301,292
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
increases expression decreases activity multiple interactions |
ISO |
Vitamin K 3 results in increased expression of HMGCR mRNA Vitamin K 3 results in decreased activity of HMGCR protein manganese protoporphyrin inhibits the reaction [Vitamin K 3 results in decreased activity of HMGCR protein]; tempol inhibits the reaction [Vitamin K 3 results in decreased activity of HMGCR protein] |
CTD |
PMID:12414654 PMID:21257924 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HMGCS2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
EXP ISO |
Vitamin K 3 results in increased expression of HMOX1 mRNA |
CTD |
PMID:12414654 PMID:19386027 PMID:23410634 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnmt |
histamine N-methyltransferase |
affects expression |
ISO |
Vitamin K 3 affects the expression of HNMT mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:6,591,804...6,623,821
Ensembl chr 3:6,591,463...6,624,012
|
|
G |
Hoxd1 |
homeo box D1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HOXD1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 3:59,665,629...59,667,769
Ensembl chr 3:59,665,629...59,667,769
|
|
G |
Hp |
haptoglobin |
affects expression |
ISO |
Vitamin K 3 affects the expression of HP mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Hsbp1 |
heat shock factor binding protein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HSBP1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:47,401,039...47,405,373
Ensembl chr19:47,400,966...47,435,821
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HSD11B2 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hsd17b11 |
hydroxysteroid (17-beta) dehydrogenase 11 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HSD17B11 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr14:5,693,304...5,743,157
Ensembl chr14:5,711,964...5,743,161
|
|
G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HSD17B4 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
affects expression multiple interactions |
ISO |
Vitamin K 3 affects the expression of HSD3B1 mRNA [Vitamin K 3 co-treated with NADP] binds to HSD3B1 protein |
CTD |
PMID:20044591 PMID:25526675 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
increases activity |
ISO |
Vitamin K 3 results in increased activity of HSF1 protein |
CTD |
PMID:34170685 |
|
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HSP90B1 mRNA |
CTD |
PMID:20829426 |
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
affects expression increases expression |
ISO |
Vitamin K 3 affects the expression of HSPA1A mRNA Vitamin K 3 results in increased expression of HSPA1A mRNA |
CTD |
PMID:12414654 PMID:20044591 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
increases expression |
ISO |
Vitamin K 3 results in increased expression of HSPA1B mRNA |
CTD |
PMID:12414654 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions increases expression |
ISO |
Metyrapone promotes the reaction [Vitamin K 3 results in increased expression of HSPA5 protein]; S 3483 promotes the reaction [Vitamin K 3 results in increased expression of HSPA5 protein] |
CTD |
PMID:19819344 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa6l-ps1 |
heat shock protein family A (Hsp70) member 6 like, pseudogene 1 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of HSPA6 mRNA |
CTD |
PMID:12414654 |
|
NCBI chr13:83,273,176...83,274,317
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of HSPB1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of HTATIP2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
|
|
G |
Iars1 |
isoleucyl-tRNA synthetase 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of IARS1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:14,940,919...14,987,277
Ensembl chr17:14,940,924...14,987,237
|
|
G |
Ica1 |
islet cell autoantigen 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ICA1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:36,656,475...36,804,705
Ensembl chr 4:36,656,475...36,804,298
|
|
G |
Icoslg |
inducible T-cell co-stimulator ligand |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of ICOSL mRNA |
CTD |
PMID:25270620 |
|
NCBI chr20:10,600,420...10,610,718
Ensembl chr20:10,600,420...10,610,703
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ID1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Ier5 |
immediate early response 5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of IER5 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr13:67,270,134...67,272,226
Ensembl chr13:67,270,135...67,272,227
|
|
G |
Ifi30 |
IFI30, lysosomal thiol reductase |
affects expression |
ISO |
Vitamin K 3 affects the expression of IFI30 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr16:18,675,590...18,679,655
Ensembl chr16:18,675,613...18,681,175
|
|
G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of IFIT3 mRNA |
CTD |
PMID:20829426 |
|
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
|
|
G |
Ift22 |
intraflagellar transport 22 |
affects expression |
ISO |
Vitamin K 3 affects the expression of IFT22 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr12:19,759,072...19,768,859
Ensembl chr12:19,761,790...19,768,809
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
affects expression |
ISO |
Vitamin K 3 affects the expression of IGF1R mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igf2r |
insulin-like growth factor 2 receptor |
affects expression |
ISO |
Vitamin K 3 affects the expression of IGF2R mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of IGFBP2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of IGFBP5 mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
|
|
G |
Il11 |
interleukin 11 |
affects expression |
ISO |
Vitamin K 3 affects the expression of IL11 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions increases expression increases secretion |
EXP ISO |
Acetaminophen inhibits the reaction [Vitamin K 3 results in increased expression of IL1A mRNA]; Acetaminophen inhibits the reaction [Vitamin K 3 results in increased secretion of IL1A protein] [IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Vitamin K 3 |
CTD |
PMID:19265712 PMID:19362101 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases secretion increases expression |
EXP |
Acetaminophen inhibits the reaction [Vitamin K 3 results in increased expression of IL1B mRNA]; Acetaminophen inhibits the reaction [Vitamin K 3 results in increased secretion of IL1B protein] |
CTD |
PMID:19265712 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Vitamin K 3 |
CTD |
PMID:19362101 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ilf2 |
interleukin enhancer binding factor 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ILF2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:175,952,174...175,971,191
Ensembl chr 2:175,952,186...175,971,337
|
|
G |
Inhbb |
inhibin subunit beta B |
affects expression increases expression |
ISO |
Vitamin K 3 affects the expression of INHBB mRNA Vitamin K 3 results in increased expression of INHBB mRNA |
CTD |
PMID:12414654 PMID:20044591 |
|
NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832
|
|
G |
Insig2 |
insulin induced gene 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of INSIG2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923
|
|
G |
Ints10 |
integrator complex subunit 10 |
affects expression |
ISO |
Vitamin K 3 affects the expression of INTS10 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr16:20,915,223...20,947,146
Ensembl chr16:20,916,082...20,967,610
|
|
G |
Ipo7 |
importin 7 |
affects expression |
ISO |
Vitamin K 3 affects the expression of IPO7 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:164,062,702...164,102,938
Ensembl chr 1:164,062,702...164,102,938
|
|
G |
Irf2bp2 |
interferon regulatory factor 2 binding protein 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of IRF2BP2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:54,559,417...54,565,096
Ensembl chr19:54,560,128...54,566,642
|
|
G |
Irf5 |
interferon regulatory factor 5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of IRF5 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267
|
|
G |
Irx5 |
iroquois homeobox 5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of IRX5 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:14,639,052...14,643,911
Ensembl chr19:14,624,225...14,642,318
|
|
G |
Isg20 |
interferon stimulated exonuclease gene 20 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ISG20 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
|
|
G |
Isg20l2 |
interferon stimulated exonuclease gene 20-like 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ISG20L2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:173,396,780...173,407,102
Ensembl chr 2:173,396,780...173,406,614
|
|
G |
Itga4 |
integrin subunit alpha 4 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ITGA4 mRNA |
CTD |
PMID:20829426 |
|
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
|
|
G |
Itpr3 |
inositol 1,4,5-trisphosphate receptor, type 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ITPR3 mRNA |
CTD |
PMID:20044591 PMID:23410634 |
|
NCBI chr20:5,136,968...5,202,339
Ensembl chr20:5,136,441...5,202,337
|
|
G |
Itprid2 |
ITPR interacting domain containing 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of ITPRID2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:64,536,707...64,573,978
Ensembl chr 3:64,536,707...64,573,978
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of JAG1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
|
|
G |
Jak1 |
Janus kinase 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of JAK1 mRNA |
CTD |
PMID:20829426 |
|
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
|
|
G |
Jak3 |
Janus kinase 3 |
multiple interactions increases phosphorylation |
ISO |
[[Vitamin K 3 results in increased phosphorylation of JAK3 protein] which results in increased phosphorylation of and affects the localization of ELAVL1 protein] inhibits the reaction [ELAVL1 protein binds to and results in decreased degradation of SIRT1 mRNA]; [[Vitamin K 3 results in increased phosphorylation of JAK3 protein] which results in increased phosphorylation of and affects the localization of ELAVL1 protein] inhibits the reaction [ELAVL1 protein binds to and results in decreased degradation of VHL mRNA]; [Vitamin K 3 results in increased phosphorylation of JAK3 protein] which results in increased phosphorylation of and affects the localization of ELAVL1 protein; JAK3 protein promotes the reaction [Vitamin K 3 results in increased phosphorylation of ELAVL1 protein] |
CTD |
PMID:24106086 |
|
NCBI chr16:18,386,330...18,398,542
Ensembl chr16:18,386,405...18,398,536
|
|
G |
Jaml |
junction adhesion molecule like |
affects expression |
ISO |
Vitamin K 3 affects the expression of JAML mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:45,384,836...45,415,459
Ensembl chr 8:45,383,495...45,416,565
|
|
G |
Jarid2 |
jumonji and AT-rich interaction domain containing 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of JARID2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:19,777,487...19,957,696
Ensembl chr17:19,777,266...19,955,690
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Vitamin K 3 results in increased expression of JUN mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kank1 |
KN motif and ankyrin repeat domains 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of KANK1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:222,877,962...223,074,514
Ensembl chr 1:222,877,622...223,074,514
|
|
G |
Kat2a |
lysine acetyltransferase 2A |
affects expression |
ISO |
Vitamin K 3 affects the expression of KAT2A mRNA |
CTD |
PMID:23410634 |
|
NCBI chr10:85,632,216...85,640,561
Ensembl chr10:85,632,216...85,640,166
|
|
G |
Kazald1 |
Kazal-type serine peptidase inhibitor domain 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of KAZALD1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:243,939,596...243,943,060
Ensembl chr 1:243,939,647...243,943,059
|
|
G |
Kbtbd11 |
kelch repeat and BTB domain containing 11 |
affects expression |
ISO |
Vitamin K 3 affects the expression of KBTBD11 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr16:74,618,291...74,638,010
Ensembl chr16:74,615,792...74,637,736
|
|
G |
Kcnj14 |
potassium inwardly-rectifying channel, subfamily J, member 14 |
affects expression |
ISO |
Vitamin K 3 affects the expression of KCNJ14 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:96,293,159...96,300,810
Ensembl chr 1:96,293,435...96,495,459
|
|
G |
Kcnj16 |
potassium inwardly-rectifying channel, subfamily J, member 16 |
affects expression |
ISO |
Vitamin K 3 affects the expression of KCNJ16 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:95,990,009...96,021,356
Ensembl chr10:95,960,725...96,021,702
|
|
G |
Kcnn4 |
potassium calcium-activated channel subfamily N member 4 |
affects expression |
ISO |
Vitamin K 3 affects the expression of KCNN4 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340
|
|
G |
Kctd10 |
potassium channel tetramerization domain containing 10 |
affects expression |
ISO |
Vitamin K 3 affects the expression of KCTD10 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr12:42,230,159...42,248,792
Ensembl chr12:42,230,269...42,248,783
|
|
G |
Kctd21 |
potassium channel tetramerization domain containing 21 |
affects expression |
ISO |
Vitamin K 3 affects the expression of KCTD21 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 1:151,650,074...151,669,775
Ensembl chr 1:151,650,104...151,667,645
|
|
G |
Kdm2b |
lysine demethylase 2B |
affects expression |
ISO |
Vitamin K 3 affects the expression of KDM2B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr12:33,566,530...33,701,366
Ensembl chr12:33,574,657...33,701,355
|
|
G |
Kdm3a |
lysine demethylase 3A |
affects expression |
ISO |
Vitamin K 3 affects the expression of KDM3A mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 4:103,630,907...103,675,073
Ensembl chr 4:103,630,908...103,675,073
|
|
G |
Kdm3b |
lysine demethylase 3B |
affects expression |
ISO |
Vitamin K 3 affects the expression of KDM3B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr18:26,380,859...26,436,701
Ensembl chr18:26,380,964...26,436,628
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
multiple interactions decreases expression |
ISO |
[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Vitamin K 3 Vitamin K 3 results in decreased expression of KEAP1 mRNA |
CTD |
PMID:19608619 PMID:23410634 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Khdrbs1 |
KH RNA binding domain containing, signal transduction associated 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of KHDRBS1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:142,051,844...142,089,175
Ensembl chr 5:142,063,570...142,089,180
|
|
G |
Kiaa1549 |
KIAA1549 homolog |
affects expression |
ISO |
Vitamin K 3 affects the expression of KIAA1549 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:66,840,674...66,968,407
Ensembl chr 4:66,760,162...66,968,436
|
|
G |
Kif13b |
kinesin family member 13B |
affects expression |
ISO |
Vitamin K 3 affects the expression of KIF13B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr15:38,908,257...39,066,021
Ensembl chr15:38,924,624...39,084,879
|
|
G |
Kif15 |
kinesin family member 15 |
affects expression |
ISO |
Vitamin K 3 affects the expression of KIF15 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 8:122,601,888...122,672,750
Ensembl chr 8:122,601,897...122,672,750
|
|
G |
Kif1b |
kinesin family member 1B |
affects expression |
ISO |
Vitamin K 3 affects the expression of KIF1B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:159,607,697...159,742,778
Ensembl chr 5:159,561,271...159,742,778
|
|
G |
Kif23 |
kinesin family member 23 |
affects expression |
ISO |
Vitamin K 3 affects the expression of KIF23 mRNA |
CTD |
PMID:20044591 PMID:23410634 |
|
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
|
|
G |
Kif2c |
kinesin family member 2C |
affects expression |
ISO |
Vitamin K 3 affects the expression of KIF2C mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
|
|
G |
Kiss1r |
KISS1 receptor |
affects expression |
ISO |
Vitamin K 3 affects the expression of KISS1R mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 7:9,785,135...9,790,283
Ensembl chr 7:9,785,135...9,788,793
|
|
G |
Klf10 |
KLF transcription factor 10 |
affects expression |
ISO |
Vitamin K 3 affects the expression of KLF10 mRNA |
CTD |
PMID:20044591 PMID:23410634 |
|
NCBI chr 7:69,467,658...69,473,726
Ensembl chr 7:69,465,619...69,473,994
|
|
G |
Klf11 |
KLF transcription factor 11 |
affects expression |
ISO |
Vitamin K 3 affects the expression of KLF11 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:41,285,699...41,297,548
Ensembl chr 6:41,285,842...41,297,550
|
|
G |
Klf6 |
KLF transcription factor 6 |
affects expression multiple interactions increases expression |
ISO |
Vitamin K 3 affects the expression of KLF6 mRNA [Arachidonic Acid co-treated with Vitamin K 3] results in increased expression of KLF6 protein; [CYP2E1 protein co-treated with Vitamin K 3 co-treated with Arachidonic Acid] results in increased expression of KLF6 protein; [CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein; Buthionine Sulfoximine promotes the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; CAT protein inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Dicumarol inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; S-ethyl glutathione inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Vitamin E inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Vitamin K 3 promotes the reaction [CYP2E1 protein results in increased expression of KLF6 mRNA alternative form]; Vitamin K 3 promotes the reaction [CYP2E1 protein results in increased expression of KLF6 mRNA] Vitamin K 3 results in increased expression of KLF6 mRNA; Vitamin K 3 results in increased expression of KLF6 mRNA alternative form; Vitamin K 3 results in increased expression of KLF6 protein |
CTD |
PMID:20044591 PMID:22486562 |
|
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
|
|
G |
Kng1 |
kininogen 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of KNG1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
|
|
G |
Kpnb1 |
karyopherin subunit beta 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of KPNB1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,145,420...82,174,605
|
|
G |
Kri1 |
KRI1 homolog |
affects expression |
ISO |
Vitamin K 3 affects the expression of KRI1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:19,817,005...19,831,516
Ensembl chr 8:19,817,017...19,831,392
|
|
G |
Krt10 |
keratin 10 |
affects expression |
ISO |
Vitamin K 3 affects the expression of KRT10 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:84,338,695...84,343,279
Ensembl chr10:84,338,706...84,343,701
|
|
G |
Krt23 |
keratin 23 |
affects expression |
ISO |
Vitamin K 3 affects the expression of KRT23 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:84,434,445...84,450,773
Ensembl chr10:84,434,380...84,450,983
|
|
G |
Krt8 |
keratin 8 |
multiple interactions increases phosphorylation |
ISO |
Acetylcysteine inhibits the reaction [Vitamin K 3 results in increased phosphorylation of KRT8 protein]; U 0126 inhibits the reaction [Vitamin K 3 results in increased phosphorylation of KRT8 protein] |
CTD |
PMID:15939799 |
|
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
|
|
G |
Kynu |
kynureninase |
affects expression |
ISO |
Vitamin K 3 affects the expression of KYNU mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488
|
|
G |
Lama5 |
laminin subunit alpha 5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of LAMA5 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:167,270,296...167,318,370
Ensembl chr 3:167,270,296...167,318,451
|
|
G |
Lamb2 |
laminin subunit beta 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of LAMB2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:109,178,367...109,190,552
Ensembl chr 8:109,178,409...109,190,549
|
|
G |
Lamc1 |
laminin subunit gamma 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of LAMC1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr13:65,374,372...65,501,492
Ensembl chr13:65,374,372...65,501,492
|
|
G |
Lamtor2 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of LAMTOR2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:174,008,556...174,011,950
Ensembl chr 2:174,008,548...174,013,013
|
|
G |
Large1 |
LARGE xylosyl- and glucuronyltransferase 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of LARGE1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:11,603,129...12,048,930
Ensembl chr19:11,603,129...12,048,930
|
|
G |
Larp1b |
La ribonucleoprotein 1B |
affects expression |
ISO |
Vitamin K 3 affects the expression of LARP1B mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:123,936,057...123,969,254
Ensembl chr 2:123,935,983...123,968,896
|
|
G |
Larp6 |
La ribonucleoprotein 6, translational regulator |
affects expression |
ISO |
Vitamin K 3 affects the expression of LARP6 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:61,183,744...61,205,548
Ensembl chr 8:61,184,116...61,205,535
|
|
G |
Las1l |
LAS1-like, ribosome biogenesis factor |
affects expression |
ISO |
Vitamin K 3 affects the expression of LAS1L mRNA |
CTD |
PMID:20044591 |
|
NCBI chr X:60,851,969...60,873,717
Ensembl chr X:60,851,962...60,873,687
|
|
G |
Lats2 |
large tumor suppressor kinase 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of LATS2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr15:31,825,068...31,877,193
Ensembl chr15:31,825,092...31,877,220
|
|
G |
Lbp |
lipopolysaccharide binding protein |
affects expression |
ISO |
Vitamin K 3 affects the expression of LBP mRNA |
CTD |
PMID:20829426 |
|
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
|
|
G |
Lbr |
lamin B receptor |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of LBR mRNA |
CTD |
PMID:12414654 |
|
NCBI chr13:93,539,386...93,564,026
Ensembl chr13:93,538,920...93,564,017
|
|
G |
Ldha |
lactate dehydrogenase A |
affects expression |
ISO |
Vitamin K 3 affects the expression of LDHA mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Ldhd |
lactate dehydrogenase D |
affects expression |
ISO |
Vitamin K 3 affects the expression of LDHD mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:39,583,529...39,588,397
Ensembl chr19:39,573,621...39,595,575
|
|
G |
Ldlr |
low density lipoprotein receptor |
increases expression |
ISO |
Vitamin K 3 results in increased expression of LDLR mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lef1 |
lymphoid enhancer binding factor 1 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of LEF1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
|
|
G |
Leo1 |
LEO1 homolog, Paf1/RNA polymerase II complex component |
affects expression |
ISO |
Vitamin K 3 affects the expression of LEO1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:76,199,547...76,223,983
Ensembl chr 8:76,199,099...76,223,983
|
|
G |
Lep |
leptin |
multiple interactions increases expression |
ISO |
1,2-linoleoylphosphatidylcholine inhibits the reaction [Vitamin K 3 results in increased expression of LEP mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Vitamin K 3 results in increased expression of LEP mRNA]; S-Adenosylmethionine inhibits the reaction [Vitamin K 3 results in increased expression of LEP mRNA]; SB 203580 inhibits the reaction [Vitamin K 3 results in increased expression of LEP mRNA] |
CTD |
PMID:16996477 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Leprot |
leptin receptor overlapping transcript |
affects expression |
ISO |
Vitamin K 3 affects the expression of LEPROT mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:116,289,843...116,301,951
Ensembl chr 5:116,289,822...116,301,988
|
|
G |
Lgals8 |
galectin 8 |
affects expression |
ISO |
Vitamin K 3 affects the expression of LGALS8 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:58,024,652...58,052,764
Ensembl chr17:58,028,105...58,052,764
|
|
G |
Lgr5 |
leucine rich repeat containing G protein coupled receptor 5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of LGR5 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 7:51,087,059...51,221,882
Ensembl chr 7:51,088,239...51,222,446
|
|
G |
Lgsn |
lengsin, lens protein with glutamine synthetase domain |
affects expression |
ISO |
Vitamin K 3 affects the expression of LGSN mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:33,416,362...33,447,919
Ensembl chr 9:33,420,484...33,447,907
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions |
EXP |
Vitamin K 3 results in decreased expression of and results in decreased secretion of LHB protein |
CTD |
PMID:30536483 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lhx6 |
LIM homeobox 6 |
affects expression |
ISO |
Vitamin K 3 affects the expression of LHX6 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:19,432,439...19,456,268
Ensembl chr 3:19,433,494...19,456,061
|
|
G |
Lif |
LIF, interleukin 6 family cytokine |
increases expression |
ISO |
Vitamin K 3 results in increased expression of LIF mRNA |
CTD |
PMID:12414654 PMID:23410634 |
|
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
|
|
G |
Lmbr1 |
limb development membrane protein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of LMBR1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 4:5,974,687...6,146,348
Ensembl chr 4:5,974,750...6,146,368
|
|
G |
Lmcd1 |
LIM and cysteine-rich domains 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of LMCD1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:145,393,153...145,452,049
Ensembl chr 4:145,393,145...145,452,046
|
|
G |
Lmnb1 |
lamin B1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of LMNB1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
|
|
G |
Lonp1 |
lon peptidase 1, mitochondrial |
affects expression |
ISO |
Vitamin K 3 affects the expression of LONP1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
|
|
G |
Lox |
lysyl oxidase |
affects expression |
ISO |
Vitamin K 3 affects the expression of LOX mRNA |
CTD |
PMID:23410634 |
|
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
|
|
G |
Lrfn3 |
leucine rich repeat and fibronectin type III domain containing 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of LRFN3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:85,616,862...85,623,725
Ensembl chr 1:85,616,868...85,623,725
|
|
G |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of LRIG1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:127,130,899...127,230,956
Ensembl chr 4:127,130,898...127,231,513
|
|
G |
Lrp1 |
LDL receptor related protein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of LRP1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910
|
|
G |
Lrp6 |
LDL receptor related protein 6 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of LRP6 mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 4:167,269,856...167,400,364
Ensembl chr 4:167,270,353...167,400,497
|
|
G |
Lrrc8e |
leucine rich repeat containing 8 VRAC subunit E |
affects expression |
ISO |
Vitamin K 3 affects the expression of LRRC8E mRNA |
CTD |
PMID:20044591 |
|
NCBI chr12:2,578,240...2,589,407
Ensembl chr12:2,578,315...2,589,412
|
|
G |
Lrwd1 |
leucine-rich repeats and WD repeat domain containing 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of LRWD1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr12:20,530,035...20,543,078
Ensembl chr12:20,530,012...20,549,536
|
|
G |
Lsm14a |
LSM14A mRNA processing body assembly factor |
affects expression |
ISO |
Vitamin K 3 affects the expression of LSM14A mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:86,964,800...87,009,325
Ensembl chr 1:86,964,828...87,009,276
|
|
G |
Lta4h |
leukotriene A4 hydrolase |
affects expression |
ISO |
Vitamin K 3 affects the expression of LTA4H mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 7:27,969,796...28,001,600
Ensembl chr 7:27,969,789...28,001,600
|
|
G |
Ltv1 |
LTV1 ribosome biogenesis factor |
affects expression |
ISO |
Vitamin K 3 affects the expression of LTV1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:7,565,673...7,578,398
Ensembl chr 1:7,565,669...7,578,563
|
|
G |
Lyar |
Ly1 antibody reactive |
affects expression |
ISO |
Vitamin K 3 affects the expression of LYAR mRNA |
CTD |
PMID:20044591 |
|
NCBI chr14:72,576,878...72,590,854
Ensembl chr14:72,576,879...72,590,612
|
|
G |
Mab21l4 |
mab-21 like 4 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MAB21L4 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:93,690,455...93,701,267
Ensembl chr 9:93,690,999...93,700,506
|
|
G |
Maf |
MAF bZIP transcription factor |
affects expression |
ISO |
Vitamin K 3 affects the expression of MAF mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:43,353,867...43,713,162
Ensembl chr19:43,360,342...43,712,365
|
|
G |
Maff |
MAF bZIP transcription factor F |
affects expression |
ISO |
Vitamin K 3 affects the expression of MAFF mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Mafg |
MAF bZIP transcription factor G |
increases expression affects expression |
ISO |
Vitamin K 3 results in increased expression of MAFG mRNA Vitamin K 3 affects the expression of MAFG mRNA |
CTD |
PMID:12414654 PMID:20044591 |
|
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Maged1 |
MAGE family member D1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MAGED1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr X:59,422,715...59,429,381
Ensembl chr X:59,422,717...59,429,364
|
|
G |
Maob |
monoamine oxidase B |
multiple interactions decreases activity |
ISO |
Vitamin K 3 inhibits the reaction [MAOB protein results in increased oxidation of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] Vitamin K 3 results in decreased activity of MAOB protein |
CTD |
PMID:21554916 |
|
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions |
ISO |
[Metyrapone co-treated with Vitamin K 3] results in increased expression of MAP1LC3B protein; [S 3483 co-treated with Vitamin K 3] results in increased expression of MAP1LC3B protein |
CTD |
PMID:19819344 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Map4 |
microtubule-associated protein 4 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MAP4 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:109,925,233...110,064,370
Ensembl chr 8:109,925,575...110,064,362
|
|
G |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MAP4K4 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:42,200,708...42,326,708
Ensembl chr 9:42,200,278...42,326,698
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation increases activity |
EXP ISO |
Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [Vitamin K 3 results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Vitamin K 3 results in increased phosphorylation of MAPK1 protein] [1,2-linoleoylphosphatidylcholine co-treated with S-Adenosylmethionine] inhibits the reaction [Vitamin K 3 results in increased phosphorylation of MAPK1 protein] Vitamin K 3 results in increased activity of MAPK1 protein schizandrin B promotes the reaction [Vitamin K 3 results in increased activity of MAPK1 protein] |
CTD |
PMID:11880281 PMID:16310883 PMID:16507596 PMID:16996477 PMID:21250784 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk10 |
mitogen activated protein kinase 10 |
decreases activity multiple interactions |
ISO EXP |
Vitamin K 3 results in decreased activity of MAPK10 protein Vitamin K 3 results in increased phosphorylation of and results in increased activity of MAPK10 protein |
CTD |
PMID:10531305 PMID:19386027 |
|
NCBI chr14:6,497,662...6,790,109
Ensembl chr14:6,497,707...6,786,201
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation increases activity |
EXP ISO |
Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [Vitamin K 3 results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Vitamin K 3 results in increased phosphorylation of MAPK3 protein] [1,2-linoleoylphosphatidylcholine co-treated with S-Adenosylmethionine] inhibits the reaction [Vitamin K 3 results in increased phosphorylation of MAPK3 protein] Vitamin K 3 results in increased activity of MAPK3 protein schizandrin B promotes the reaction [Vitamin K 3 results in increased activity of MAPK3 protein] |
CTD |
PMID:11880281 PMID:16310883 PMID:16507596 PMID:16996477 PMID:21250784 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions increases phosphorylation affects response to substance increases activity |
EXP ISO |
Vitamin K 3 results in increased phosphorylation of and results in increased activity of MAPK8 protein Vitamin K 3 results in increased phosphorylation of MAPK8 protein MAPK8 protein affects the susceptibility to Vitamin K 3 Vitamin K 3 results in increased activity of MAPK8 protein |
CTD |
PMID:12215205 PMID:16310883 PMID:19386027 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mat2a |
methionine adenosyltransferase 2A |
affects expression |
ISO |
Vitamin K 3 affects the expression of MAT2A mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:104,489,877...104,495,447
Ensembl chr 4:104,488,466...104,495,493
|
|
G |
Mbd2 |
methyl-CpG binding domain protein 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MBD2 mRNA |
CTD |
PMID:20829426 |
|
NCBI chr18:64,174,002...64,240,795
Ensembl chr18:64,174,002...64,240,794
|
|
G |
Mc1r |
melanocortin 1 receptor |
affects expression |
ISO |
Vitamin K 3 affects the expression of MC1R mRNA |
CTD |
PMID:20044591 |
|
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
|
|
G |
Mccc1 |
methylcrotonyl-CoA carboxylase subunit 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MCCC1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:118,799,147...118,851,181
Ensembl chr 2:118,799,150...118,851,222
|
|
G |
Mcf2l |
MCF.2 cell line derived transforming sequence-like |
affects expression |
ISO |
Vitamin K 3 affects the expression of MCF2L mRNA |
CTD |
PMID:20044591 |
|
NCBI chr16:76,507,133...76,652,893
Ensembl chr16:76,507,133...76,652,733
|
|
G |
Mcm3 |
minichromosome maintenance complex component 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MCM3 mRNA |
CTD |
PMID:20044591 PMID:23410634 |
|
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
|
|
G |
Mcm5 |
minichromosome maintenance complex component 5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MCM5 mRNA |
CTD |
PMID:20044591 PMID:23410634 |
|
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
|
|
G |
Mcm6 |
minichromosome maintenance complex component 6 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MCM6 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960
|
|
G |
Mcmbp |
minichromosome maintenance complex binding protein |
affects expression |
ISO |
Vitamin K 3 affects the expression of MCMBP mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:183,270,598...183,316,975
Ensembl chr 1:183,271,980...183,316,975
|
|
G |
Mdc1 |
mediator of DNA damage checkpoint 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MDC1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr20:2,893,693...2,912,394
Ensembl chr20:2,895,505...2,910,240
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
multiple interactions decreases expression |
ISO |
EUK-134 inhibits the reaction [Vitamin K 3 results in decreased expression of MDM2 protein] |
CTD |
PMID:25005833 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Me1 |
malic enzyme 1 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of ME1 mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Med9 |
mediator complex subunit 9 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MED9 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:44,750,667...44,765,464
Ensembl chr10:44,750,698...44,765,464
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
increases expression |
ISO |
Vitamin K 3 results in increased expression of MET mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Metap1 |
methionyl aminopeptidase 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of METAP1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:226,991,305...227,024,360
Ensembl chr 2:226,991,301...227,024,434
|
|
G |
Mex3d |
mex-3 RNA binding family member D |
affects expression |
ISO |
Vitamin K 3 affects the expression of MEX3D mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 7:9,325,575...9,332,705
Ensembl chr 7:9,325,488...9,332,096
|
|
G |
Mff |
mitochondrial fission factor |
affects expression |
ISO |
Vitamin K 3 affects the expression of MFF mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:84,007,798...84,036,039
Ensembl chr 9:84,007,798...84,036,039
|
|
G |
Mfge8 |
milk fat globule EGF and factor V/VIII domain containing |
affects expression |
ISO |
Vitamin K 3 affects the expression of MFGE8 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:133,064,665...133,080,069
Ensembl chr 1:133,064,665...133,080,073
|
|
G |
Mfsd1 |
major facilitator superfamily domain containing 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MFSD1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:151,846,130...151,866,168
Ensembl chr 2:151,846,146...151,867,045
|
|
G |
Mfsd5 |
major facilitator superfamily domain containing 5 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MFSD5 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 7:133,409,096...133,411,377
Ensembl chr 7:133,402,537...133,411,396
|
|
G |
Mia2 |
MIA SH3 domain ER export factor 2 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of MIA2 mRNA |
CTD |
PMID:12414654 |
|
NCBI chr 6:76,787,508...76,885,246
Ensembl chr 6:76,787,508...76,885,211
|
|
G |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MICAL2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:166,345,853...166,530,575
Ensembl chr 1:166,345,859...166,471,719 Ensembl chr 1:166,345,859...166,471,719
|
|
G |
Mindy1 |
MINDY lysine 48 deubiquitinase 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MINDY1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:182,859,977...182,873,000
Ensembl chr 2:182,860,472...182,873,015
|
|
G |
Mitd1 |
microtubule interacting and trafficking domain containing 1 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of MITD1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 9:40,113,943...40,125,280
Ensembl chr 9:40,113,946...40,125,289
|
|
G |
Mixl1 |
Mix paired-like homeobox 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MIXL1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr13:92,422,031...92,426,065
Ensembl chr13:92,422,031...92,426,065
|
|
G |
Mlxip |
MLX interacting protein |
affects expression |
ISO |
Vitamin K 3 affects the expression of MLXIP mRNA |
CTD |
PMID:20044591 |
|
NCBI chr12:33,128,524...33,192,300
Ensembl chr12:33,128,520...33,192,374
|
|
G |
Mmd |
monocyte to macrophage differentiation-associated |
affects expression |
ISO |
Vitamin K 3 affects the expression of MMD mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:75,073,278...75,101,528
Ensembl chr10:75,073,365...75,101,528
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of MMP2 protein |
CTD |
PMID:31238027 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression |
ISO |
Vitamin K 3 results in decreased expression of MMP9 protein |
CTD |
PMID:31238027 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mnt |
MAX network transcriptional repressor |
affects expression |
ISO |
Vitamin K 3 affects the expression of MNT mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:59,699,208...59,714,848
Ensembl chr10:59,699,585...59,714,835
|
|
G |
Mogs |
mannosyl-oligosaccharide glucosidase |
affects expression |
ISO |
Vitamin K 3 affects the expression of MOGS mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:115,621,623...115,625,026
Ensembl chr 4:115,621,623...115,625,032
|
|
G |
Morc4 |
MORC family CW-type zinc finger 4 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MORC4 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr X:103,477,366...103,529,026
Ensembl chr X:103,480,603...103,528,956
|
|
G |
Mosmo |
modulator of smoothened |
affects expression |
ISO |
Vitamin K 3 affects the expression of MOSMO mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:175,217,680...175,288,521
Ensembl chr 1:175,217,545...175,288,334
|
|
G |
Mpc2 |
mitochondrial pyruvate carrier 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MPC2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr13:77,728,176...77,747,664
Ensembl chr13:77,728,250...77,747,664
|
|
G |
Mpnd |
MPN domain containing |
affects expression |
ISO |
Vitamin K 3 affects the expression of MPND mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:839,473...846,446
Ensembl chr 9:840,143...846,439
|
|
G |
Mrnip |
MRN complex interacting protein |
affects expression |
ISO |
Vitamin K 3 affects the expression of MRNIP mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:34,501,359...34,525,474
Ensembl chr10:34,501,384...34,525,469
|
|
G |
Mrpl33 |
mitochondrial ribosomal protein L33 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MRPL33 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:24,825,800...24,833,994
Ensembl chr 6:24,825,827...24,833,834
|
|
G |
Mrpl38 |
mitochondrial ribosomal protein L38 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of MRPL38 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr10:101,365,353...101,372,159
Ensembl chr10:101,365,353...101,372,171
|
|
G |
Mrps12 |
mitochondrial ribosomal protein S12 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MRPS12 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:84,025,896...84,028,896
Ensembl chr 1:84,025,899...84,028,780
|
|
G |
Mrs2 |
magnesium transporter MRS2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MRS2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:40,063,924...40,087,073
Ensembl chr17:40,063,962...40,081,887
|
|
G |
Msh2 |
mutS homolog 2 |
affects expression multiple interactions |
ISO |
Vitamin K 3 affects the expression of MSH2 mRNA MSH2 protein inhibits the reaction [POLK protein results in decreased susceptibility to Vitamin K 3] |
CTD |
PMID:20044591 PMID:31294882 |
|
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
|
|
G |
Msh6 |
mutS homolog 6 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MSH6 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:6,562,631...6,579,995
Ensembl chr 6:6,562,632...6,579,956
|
|
G |
Msmb |
microseminoprotein, beta |
affects expression |
ISO |
Vitamin K 3 affects the expression of MSMB mRNA |
CTD |
PMID:20044591 |
|
NCBI chr16:7,366,536...7,387,124
Ensembl chr16:7,366,536...7,387,123
|
|
G |
Msrb2 |
methionine sulfoxide reductase B2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MSRB2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:81,974,378...82,000,044
Ensembl chr17:81,974,196...82,000,043
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of MT1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
|
|
G |
Mt1-ps3 |
metallothionein 1, pseudogene 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MT1E mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135
|
|
G |
Mt2A |
metallothionein 2A |
increases expression |
ISO |
Vitamin K 3 results in increased expression of MT2A mRNA |
CTD |
PMID:12414654 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mta2 |
metastasis associated 1 family, member 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MTA2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:205,838,181...205,846,903
Ensembl chr 1:205,837,964...205,846,946
|
|
G |
Mtarc1 |
mitochondrial amidoxime reducing component 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MTARC1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr13:96,324,377...96,362,677
Ensembl chr13:96,339,757...96,397,796
|
|
G |
Mthfd1 |
methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MTHFD1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:94,977,862...95,045,375
Ensembl chr 6:94,977,862...95,045,372
|
|
G |
Mxd1 |
max dimerization protein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MXD1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
|
|
G |
Myadm |
myeloid-associated differentiation marker |
affects expression |
ISO |
Vitamin K 3 affects the expression of MYADM mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:65,864,180...65,874,701
Ensembl chr 1:65,864,173...65,874,035
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression affects expression |
ISO |
Vitamin K 3 results in decreased expression of MYC Vitamin K 3 affects the expression of MYC mRNA |
CTD |
PMID:10231603 PMID:20044591 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myl6 |
myosin light chain 6 |
affects expression |
ISO |
Vitamin K 3 affects the expression of MYL6 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 7:910,764...914,062
Ensembl chr 7:910,774...933,791
|
|
G |
Mylk |
myosin light chain kinase |
affects expression |
ISO |
Vitamin K 3 affects the expression of MYLK mRNA |
CTD |
PMID:23410634 |
|
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
|
|
G |
Myo10 |
myosin X |
affects expression |
ISO |
Vitamin K 3 affects the expression of MYO10 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 2:76,100,989...76,305,619
Ensembl chr 2:76,100,987...76,303,030
|
|
G |
Myo19 |
myosin XIX |
affects expression |
ISO |
Vitamin K 3 affects the expression of MYO19 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:69,753,082...69,782,450
Ensembl chr10:69,753,068...69,782,450
|
|
G |
Myrf |
myelin regulatory factor |
affects expression |
ISO |
Vitamin K 3 affects the expression of MYRF mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:206,854,175...206,886,276
Ensembl chr 1:206,854,175...206,886,157
|
|
G |
N4bp3 |
Nedd4 binding protein 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of N4BP3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:35,898,031...35,906,704
Ensembl chr10:35,899,096...35,907,001
|
|
G |
Nab1 |
Ngfi-A binding protein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of NAB1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:49,053,579...49,093,078
Ensembl chr 9:49,053,758...49,092,098
|
|
G |
Nabp1 |
nucleic acid binding protein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of NABP1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:50,098,552...50,133,982
Ensembl chr 9:50,126,726...50,134,107
|
|
G |
Nacc2 |
NACC family member 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of NACC2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:8,879,952...8,946,660
Ensembl chr 3:8,883,065...8,946,660
|
|
G |
Naglu |
N-acetyl-alpha-glucosaminidase |
affects expression |
ISO |
Vitamin K 3 affects the expression of NAGLU mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:86,001,545...86,009,049
Ensembl chr10:86,001,566...86,008,972
|
|
G |
Ncapg |
non-SMC condensin I complex, subunit G |
affects expression |
ISO |
Vitamin K 3 affects the expression of NCAPG mRNA |
CTD |
PMID:20044591 |
|
NCBI chr14:65,403,930...65,432,902
Ensembl chr14:65,404,163...65,432,902
|
|
G |
Ncaph |
non-SMC condensin I complex, subunit H |
affects expression |
ISO |
Vitamin K 3 affects the expression of NCAPH mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:114,371,937...114,399,178
Ensembl chr 3:114,371,941...114,399,180
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of NCF1 mRNA; Vitamin K 3 results in increased expression of NCF1 protein |
CTD |
PMID:16507596 PMID:25270620 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Ncf2 |
neutrophil cytosolic factor 2 |
increases expression |
ISO |
Vitamin K 3 results in increased expression of NCF2 protein |
CTD |
PMID:16507596 |
|
NCBI chr13:64,955,622...64,986,144
Ensembl chr13:64,955,503...64,986,277
|
|
G |
Ncor2 |
nuclear receptor co-repressor 2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of NCOR2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr12:31,466,418...31,628,319
Ensembl chr12:31,466,412...31,628,319
|
|
G |
Ncs1 |
neuronal calcium sensor 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of FREQ mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:14,523,220...14,568,829
Ensembl chr 3:14,523,220...14,568,829
|
|
G |
Ncstn |
nicastrin |
affects expression |
ISO |
Vitamin K 3 affects the expression of NCSTN mRNA |
CTD |
PMID:20044591 |
|
NCBI chr13:84,530,442...84,546,454
Ensembl chr13:84,530,440...84,546,454
|
|
G |
Ndc1 |
NDC1 transmembrane nucleoporin |
affects expression |
ISO |
Vitamin K 3 affects the expression of NDC1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 5:122,155,992...122,202,295
Ensembl chr 5:122,155,967...122,202,291
|
|
G |
Ndc80 |
NDC80 kinetochore complex component |
affects expression |
ISO |
Vitamin K 3 affects the expression of NDC80 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924
|
|
G |
Nde1 |
nudE neurodevelopment protein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of NDE1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr10:839,788...883,946
Ensembl chr10:839,788...883,869
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of NDRG1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Ndufb1 |
NADH:ubiquinone oxidoreductase subunit B1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of NDUFB1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 6:121,115,649...121,124,055
|
|
G |
Ndufs2 |
NADH:ubiquinone oxidoreductase core subunit S2 |
affects expression |
ISO |
Vitamin K 3 affects the expression of NDUFS2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr13:83,654,402...83,671,474
Ensembl chr13:83,654,406...83,671,420
|
|
G |
Necap1 |
NECAP endocytosis associated 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of NECAP1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 4:156,103,935...156,119,068
Ensembl chr 4:156,103,988...156,119,068
|
|
G |
Neo1 |
neogenin 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of NEO1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 8:59,273,860...59,426,486
Ensembl chr 8:59,275,569...59,430,348
|
|
G |
Net1 |
neuroepithelial cell transforming 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of NET1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:66,341,251...66,370,445
Ensembl chr17:66,340,728...66,370,441
|
|
G |
Nf2 |
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor |
affects expression |
ISO |
Vitamin K 3 affects the expression of NF2 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr14:79,627,399...79,710,709
Ensembl chr14:79,627,399...79,710,667
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions affects expression affects response to substance increases expression |
ISO |
[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Vitamin K 3 NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to Vitamin K 3] Vitamin K 3 affects the expression of NFE2L2 mRNA [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Vitamin K 3 Vitamin K 3 results in increased expression of NFE2L2 mRNA |
CTD |
PMID:19303893 PMID:19608619 PMID:20044591 PMID:20932822 PMID:23410634 PMID:26862668 More...
|
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfe2l3 |
NFE2 like bZIP transcription factor 3 |
affects expression |
ISO |
Vitamin K 3 affects the expression of NFE2L3 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 4:80,506,756...80,534,629
Ensembl chr 4:80,506,756...80,534,629
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
affects expression multiple interactions |
ISO |
Vitamin K 3 affects the expression of NFKB1 mRNA Vitamin K 3 inhibits the reaction [Nicotine results in increased activity of NFKB1 protein] |
CTD |
PMID:16598845 PMID:20044591 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
affects expression |
ISO |
Vitamin K 3 affects the expression of NFKBIA mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfkbie |
NFKB inhibitor epsilon |
affects expression |
ISO |
Vitamin K 3 affects the expression of NFKBIE mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:15,443,600...15,450,437
Ensembl chr 9:15,436,941...15,450,437
|
|
G |
Nfs1 |
NFS1 cysteine desulfurase |
affects expression |
ISO |
Vitamin K 3 affects the expression of NFS1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 3:144,637,309...144,659,660
Ensembl chr 3:144,637,309...144,659,666
|
|
G |
Nif3l1 |
NGG1 interacting factor 3 like 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of NIF3L1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 9:59,980,101...60,001,490
Ensembl chr 9:59,979,799...60,000,131
|
|
G |
Nkd1 |
NKD inhibitor of WNT signaling pathway 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of NKD1 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr19:18,476,344...18,549,380
Ensembl chr19:18,476,344...18,549,380
|
|
G |
Nmb |
neuromedin B |
affects expression |
ISO |
Vitamin K 3 affects the expression of NMB mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:134,869,446...134,875,507
Ensembl chr 1:134,869,446...134,872,190
|
|
G |
Nmd3 |
NMD3 ribosome export adaptor |
affects expression |
ISO |
Vitamin K 3 affects the expression of NMD3 mRNA |
CTD |
PMID:23410634 |
|
NCBI chr 2:154,012,973...154,038,466
Ensembl chr 2:154,013,020...154,039,259
|
|
G |
Noa1 |
nitric oxide associated 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of NOA1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr14:30,835,264...30,851,294
Ensembl chr14:30,835,247...30,851,293
|
|
G |
Nol7 |
nucleolar protein 7 |
affects expression |
ISO |
Vitamin K 3 affects the expression of NOL7 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:21,303,650...21,306,924
Ensembl chr17:21,302,624...21,307,431
|
|
G |
Nolc1 |
nucleolar and coiled-body phosphoprotein 1 |
affects expression |
ISO |
Vitamin K 3 affects the expression of NOLC1 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr 1:244,921,275...244,932,089
Ensembl chr 1:244,921,377...244,932,088
|
|
G |
Nop16 |
NOP16 nucleolar protein |
affects expression |
ISO |
Vitamin K 3 affects the expression of NOP16 mRNA |
CTD |
PMID:20044591 |
|
NCBI chr17:10,022,950...10,027,867
Ensembl chr17:10,022,932...10,027,867
|
|
G |
Nop56 |
NOP56 ribonucleoprotein |
affects expression |
| |